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SCIENTIFIC OPINION  
Scientific Opinion on Flavouring Group Evaluation 06, Revision 3 
(FGE.06Rev3): 
Straight- and branched-chain aliphatic unsaturated primary alcohols, 
aldehydes, carboxylic acids, and esters from chemical groups 1 and 41 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)2, 3  
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT  
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European 
Food Safety Authority was requested to evaluate 50 flavouring substances in the Flavouring Group 
Evaluation 6, Revision 3, using the Procedure in Commission Regulation (EC) No 1565/2000. None 
of the substances were considered to have genotoxic potential. The substances were evaluated through 
a stepwise approach (the Procedure) that integrates information on structure-activity relationships, 
intake from current uses, toxicological threshold of concern, and available data on metabolism and 
toxicity. The Panel concluded that the 50 substances [FL-no: 02.125, 02.138, 02.152, 02.170, 02.175, 
02.176, 02.195, 02.201, 02.222, 02.234, 05.061, 05.082, 05.143, 05.174, 05.203, 05.217, 05.218, 
05.220, 05.226, 08.074, 08.100, 08.102, 09.341, 09.368, 09.377, 09.567, 09.569, 09.572, 09.575, 
09.612, 09.638, 09.640, 09.643, 09.672, 09.673, 09.674, 09.831, 09.838, 09.884, 09.855, 09.871, 
09.872, 09.885, 09.897, 09.898, 09.928, 09.937, 09.938, 09.939 and 09.950] do not give rise to safety 
concerns at their levels of dietary intake, estimated on the basis of the MSDI approach. Besides the 
safety assessment of these flavouring substances, the specifications for the materials of commerce 
have also been considered. For one substance [FL-no: 09.938] an identity test is missing and for two 
substances [FL-no: 05.226 and 09.950] the range of the specific gravity is too wide. Additional, the 
                                                     
 
1  On request from the Commission, Question No EFSA-Q-EFSA-Q-2011-00997 & EFSA-Q-2011-00998, adopted on 29 
September 2011. 
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Wim Mennes, Maria Rosaria Milana, Iona Pratt, Kettil Svensson, Fidel Toldra, Detlef Wölfle.  
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stereoisomeric mixture has not been specified sufficiently for 12 substances [FL-no: 02.152, 02.222, 
05.061, 05.203, 05.218, 08.074, 08.102, 09.377, 09.640, 09.831, 09.884 and 09.885]. 
© European Food Safety Authority, 2011 
SUMMARY  
The Scientific Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (the 
Panel) was asked to provide scientific advice to the Commission on the implications for human health 
of chemically defined flavouring substances used in or on foodstuffs in the Member States. In 
particular, the Panel was requested to evaluate 50 flavouring substances in the Flavouring Group 
Evaluation 06, Revision 3 (FGE.06Rev3), using the Procedure as referred to in the Commission 
Regulation (EC) No 1565/2000. These 50 flavouring substances belong to chemical groups 1 and 4, 
Annex I of the Commission Regulation (EC) No 1565/2000. 
The present Flavouring Group Evaluation deals with 50 straight- and branched-chain unsaturated 
primary alcohols, aldehydes, carboxylic acids and esters.  
Eight candidate substances possess a chiral centre [FL-no: 02.170, 02.175, 05.143, 09.341, 09.612, 
09.871, 09.872 and 09.938]. 
Thirty-three candidate substances can exist as geometrical isomers [FL-no: 02.152, 02.195, 02.222, 
02.234, 05.061, 05.082, 05.203, 05.217, 05.218, 05.220, 05.226, 08.074, 08.102, 09.377, 09.567, 
09.569, 09.572, 09.575, 09.638, 09.640, 09.643, 09.672, 09.673, 09.674, 09.831, 09.838, 09.855, 
09.884, 09.885, 09.928, 09.937, 09.939 and 09.950]. For 12 of these substances [FL-no: 02.152, 
02.222, 05.061, 05.203, 05.218, 08.074, 08.102, 09.377, 09.640, 09.831, 09.884, 09.885] have the 
stereoisomeric mixture not been specified sufficiently.  
Forty-eight candidate substances are classified into structural class I. The remaining two substances 
[FL-no: 05.143 and 09.884] are classified into structural class II. 
Thirty-seven of the flavouring substances in the present group have been reported to occur naturally in 
a wide range of food items. 
According to the default MSDI approach, the flavouring substances in this group have intakes in 
Europe from 0.0012 to 120 microgram/capita/day, which are below the thresholds of concern value 
for both structural class I (1800 microgram/person/day) and structural class II (540 
microgram/person/day) substances.  
On the basis of the reported annual production volumes in Europe (MSDI approach), the combined 
intake of the 48 candidate substances belonging to structural class I and of the two candidate 
substances belonging to structural class II would result in a total intake of approximately 260 and 0.7 
microgram/capita/day, respectively. These values are below the thresholds of concern for structural 
class I and class II substances of 1800 and 540 microgram/person/day, respectively. The total 
combined estimated intake of 65 of the 70 supporting substances for which European annual 
production data are available and of the 48 candidate substances from structural class I is 
approximately 6700 microgram/capita/day, which exceeds the threshold of concern for structural class 
I (1800 microgram/person/day). However, the substances are expected to be efficiently metabolised 
and are not expected to saturate the metabolic pathways. 
For the substances in this group the limited data available do not give rise to safety concern with 
respect to genotoxicity and carcinogenicity.   
Except for hex-3-enyl 2-ethylbutyrate [FL-no: 09.884] the candidate substances are expected to be 
metabolised to innocuous substances at the estimated levels of use as flavouring substances. One of 
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the hydrolysis products of [FL-no: 09.884], 2-ethylbutyric acid, showed teratogenic potential in one 
mouse subcutaneous single-dose study, and is structurally related to valproic acid, which is a known 
teratogen. However, an additional study in which 2-ethylbutyric acid was given by gavage to pregnant 
rats showed a NOAEL of 200 mg/kg bw/day of 2-ethylbutyric acid. This dose is more than 4 x 107 
times higher than the MSDI for 2-ethylbutyric acid arising from the intake of the candidate substance 
[FL-no: 09.884]. Accordingly, the candidate substance [FL-no: 09.884] does not pose a safety concern 
with respect to teratogenicity when used at the level of intake as flavouring substance estimated on the 
basis of the MSDI approach. 
 
It was noted that where toxicity data were available they were consistent with the conclusions in the 
present flavouring group evaluation using the Procedure. 
It is considered that on the basis of the default MSDI approach the candidate substances would not 
give rise to safety concerns at the estimated levels of intake arising from their use as flavouring 
substances. 
When the estimated intakes were based on the mTAMDI approach they ranged from 36 to 40000 
microgram/person/day for the 47 flavouring substances from structural class I for which data have 
been provided. Thus, the intakes were all above the threshold of concern for structural class I of 1800 
microgram/person/day, except for 10 flavouring substances [FL-no: 05.061, 05.082, 05.174, 05.203, 
05.217, 05.218, 05.220, 05.226, 09.937 and 09.939]. The estimated intakes of the two flavouring 
substances assigned to structural class II, based on the mTAMDI, are 1600 and 3900 
microgram/person/day, which is above the threshold of concern for structural class II of 540 
microgram/person/day. The 10 flavouring substances [FL-no: 05.061, 05.082, 05.174, 05.203, 05.217, 
05.218, 05.220, 05.226, 09.937 and 09.939], which have mTAMDI intake estimates below the 
threshold of concern for structural class I, are also expected to be metabolised to innocuous products.  
Thus, for 39 flavouring substances considered in this Opinion, the intakes, estimated on the basis of 
the mTAMDI, exceed the relevant threshold for their structural class, to which the flavouring 
substance has been assigned. For one substance [FL-no: 09.647], no use levels were provided. 
Therefore, for these 40 substances more reliable exposure data are required. On the basis of such 
additional data, these flavouring substances should be reconsidered along the steps of the Procedure. 
Subsequently, additional data might become necessary.  
In order to determine whether the conclusion for the candidate substances can be applied to the 
material of commerce, it is necessary to consider the available specifications. Specifications including 
complete purity criteria and identity for the materials of commerce have been provided for 47 
flavouring candidate substances. For one substance [FL-no: 09.938] an identity test is missing and for 
two substances [FL-no: 05.226 and 09.950] the range of the specific gravity is too wide. Additional, 
the composition of the stereoisomeric mixture has not been specified sufficiently for 12 of the 
substances [FL-no: 02.152, 02.222, 05.061, 05.203, 05.218, 08.074, 08.102, 09.377, 09.640, 09.831, 
09.884 and 09.885].   
The final evaluation of the materials of commerce cannot be performed for 15 substances [FL-no: 
02.152, 02.222, 05.061, 05.203, 05.218, 05.226, 08.074, 08.102, 09.377, 09.640, 09.831, 09.884, 
09.885, 09.938 and 09.950], pending further information. The remaining 35 substances [FL-no: 
02.125, 02.138, 02.170, 02.175, 02.176, 02.195, 02.201, 02.234, 05.082, 05.143, 05.174, 05.217, 
05.220, 08.100, 09.341, 09.368, 09.567, 09.569, 09.572, 09.575, 09.612, 09.638, 09.643, 09.672, 
09.673, 09.674, 09.838, 09.855, 09.871, 09.872, 09.897, 09.898, 09.928, 09.937 and 09.939] would 
present no safety concern at the levels of intake estimated on the basis of the MSDI approach.  
KEYWORDS 
Straight-chain, branched-chain, unsaturated, primary alcohols, aldehydes, carboxylic acids, esters, 
flavourings, safety, FGE.06. 
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances the use of which will be authorised to 
the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2008/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and biological 
behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a). For the submission of data by the 
manufacturer, deadlines have been established by Commission Regulation (EC) No 622/2002 (EC, 
2002b).  
The FGE is revised to include substances for which data were submitted after the deadline as laid down 
in Commission Regulation (EC) No 622/2002 and to take into account additional information that has 
been made available since the previous Opinion on this FGE.  
The Revision also includes newly notified substances belonging to the same chemical groups evaluated 
in this FGE. 
After the completion of the evaluation programme the Union List of flavouring substances for use in or 
on foods in the EU shall be adopted (Article 5 (1) of Regulation (EC) No 2232/96) (EC, 1996a). 
HISTORY OF THE EVALUATION  
The first version of the Flavouring Group Evaluation 06 (FGE.06) dealt with 35 straight- and branched-
chain unsaturated primary alcohols, aldehydes, carboxylic acids, and esters. 
The first Revision of FGE.06 (FGE.06Rev1) included the assessment of 12 additional candidate 
substances [FL-no: 02.125, 02.234, 05.082, 05.203, 05.217, 05.218, 05.220, 08.102, 09.928, 09.937, 
09.938 and 09.939]. For [FL-no: 02.125] acute toxicity data have been provided. Additional information 
on 19 substances [FL-no: 02.152, 02.170, 02.195, 02.222, 05.061, 08.074, 09.377, 09.567, 09.569, 
09.572, 09.575, 09.638, 09.640, 09.643, 09.672, 09.673, 09.831, 09.884 and 09.885] was made 
available since FGE.06 was published. 
The second Revision of FGE.06, FGE.06Rev2, included the assessment of one additional candidate 
substance [FL-no: 09.674]. No toxicity and/or metabolism data were provided for this substance. 
Furthermore, for 24 substances [FL-no: 02.152, 02.175, 02.222, 02.234, 05.061, 05.082, 05.143, 
05.203, 05.217, 05.218, 08.074, 08.102, 09.341, 09.377, 09.612, 09.640, 09.831, 09.871, 09.872, 
09.884, 09.885, 09.937, 09.938 and 09.939] (EFFA, 2010a), information from Industry on 
stereoisomeric composition and missing specifications, received after publication of the last revision, 
was included in Revision 2. 
FGE Opinion adopted 
by EFSA 
Link No. of candidate 
substances 
FGE.06 7 October 2004 http://www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178620762005.htm 
35 
FGE.06Rev1 7 February 2007 http://www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1178710471245.htm 
47 
FGE.06Rev2 30 September 2010 http://www.efsa.europa.eu/en/efsajournal/pub/1844.htm 48 
FGE.06Rev3 28 September 2011  50 
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The present revision of FGE.06, FGE.06Rev3, includes the assessment of two additional candidate 
substances [FL-no: 05.226 and 09.950]. No toxicity or metabolism data were provided for the two new 
substances. A search in open literature did not provide any further data on toxicity or metabolism for 
these substances. Furthermore, information from Industry on missing specifications received after 
publication of the last revision is included in the present revision (EFFA, 2011a). 
TERMS OF REFERENCE 
The European Food Safety Authority (EFSA) is requested to carry out a risk assessment on flavouring 
substances in the Register (Commission decision 1999/217/EC), according to Commission Regulation 
(EC) No 1565/2000 (EC, 2000a), prior to their authorisation and inclusion in the Union list (Regulation 
(EC) No 1334/2008). In addition, the Commission requested EFSA to evaluate newly notified 
flavouring substances, where possible, before finalising the evaluation programme. The evaluation 
programme was finalised at the end of 2009. 
After the finalisation of the evaluation programme, in their letter of the 12th April 2010, the Commission 
requested EFSA to carry out an evaluation of the flavouring substances E-4-undecenal [FL-no: 05.226] 
and Z-5-octenyl acetate [FL-no: 09.950], also according to Commission Regulation (EC) No 1565/2000 
(EC, 2000a). 
ASSESSMENT 
1. Presentation of the Substances in Flavouring Group Evaluation 06, Revision 3 
1.1. Description 
The present Flavouring Group Evaluation 6 Revision 3, FGE.06Rev3, using the Procedure as referred to 
in the Commission Regulation (EC) No 1565/2000 (the Procedure – shown in schematic form in Annex 
I of this FGE), deals with 50 straight- and branched-chain aliphatic unsaturated primary alcohols, 
aldehydes, carboxylic acids and esters. These flavouring substances (candidate substances) belong to 
chemical groups 1 and 4 of Annex I of Regulation (EC) No 1565/2000 (EC, 2000a). 
The flavouring substances under consideration, with their chemical Register name, FLAVIS (FL-), 
Chemical Abstract Service (CAS-), Council of Europe (CoE-), and Flavor and Extract Manufacturers’ 
Association (FEMA-) numbers, structure and specifications, are listed in Table 1. This group of 
candidate flavouring substances includes 28 straight or branched-chain esters [FL-no: 09.341, 09.368, 
09.377, 09.567, 09.569, 09.572, 09.575, 09.612, 09.638, 09.640, 09.643, 09.672, 09.673, 09.674, 
09.831, 09.838, 09.855, 09.871, 09.872, 09.884, 09.885, 09.897, 09.898, 09.928, 09.937, 09.938, 
09.939 and 09.950], 10 straight or branched-chain alcohols [FL-no: 02.125, 02.138, 02.152, 02.170, 
02.175, 02.176, 02.195, 02.201, 02.222 and 02.234], nine straight or branched-chain aldehydes [FL-no: 
05.061, 05.082, 05.143, 05.174, 05.203, 05.217, 05.218, 05.220 and 05.226], and three straight or 
branched-chain carboxylic acids [FL-no: 08.074, 08.100 and 08.102].  
The outcome of the safety evaluation is summarised in Table 2a. 
The hydrolysis products of the candidate esters are listed in Table 2b. 
The candidate substances are structurally related to flavouring substances (supporting substances) 
evaluated at the 49th, 51st or 61st meetings of the Joint FAO/WHO Expert Committee on Food Additives 
(the JECFA) (JECFA, 1999b; JECFA, 2000a; JECFA, 2004a). That is, they are structurally related to 26 
esters derived from branched-chain terpenoid alcohols and aliphatic acyclic linear and branched-chain 
carboxylic acids (JECFA, 1998a) or to 44 linear and branched-chain aliphatic, unsaturated, 
unconjugated alcohols, aldehydes, carboxylic acids and related esters (JECFA, 1999a; JECFA, 2004b), 
previously evaluated by the JECFA. The names and structures of the 70 supporting substances are listed 
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in Table 3, together with their evaluation status (CoE, 1992; JECFA, 1999b; JECFA, 2000a; JECFA, 
2004a; SCF, 1995).  
Additional substances evaluated by the JECFA and structurally related to the 70 supporting substances 
are also taken into consideration in FGE.06Rev3 regarding toxicity and metabolism studies. 
1.2. Stereoisomers 
It is recognised that geometrical and optical isomers of substances may have different properties. Their 
flavour may be different, they may have different chemical properties resulting in possible variability in 
their absorption, distribution, metabolism, elimination and toxicity. Thus information must be provided 
on the configuration of the flavouring substance, i.e. whether it is one of the geometrical/optical 
isomers, or a defined mixture of stereoisomers. The available specifications of purity will be considered 
in order to determine whether the safety evaluation carried out for candidate substances for which 
stereoisomers may exist can be applied to the material of commerce. Flavouring substances with 
different configurations should have individual chemical names and codes (CAS number, FLAVIS 
number etc.). 
Eight flavouring substances possess a chiral centre [FL-no: 02.170, 02.175, 05.143, 09.341, 09.612, 
09.871, 09.872 and 09.938]. Industry has specified the isomeric composition. 
Due to the presence and the position of double bonds, 33 substances can exist as geometrical isomers 
[FL-no: 02.152, 02.195, 02.222, 02.234, 05.061, 05.082, 05.203, 05.217, 05.218, 05.220, 05.226, 
08.074, 08.102, 09.377, 09.567, 09.569, 09.572, 09.575, 09.638, 09.640, 09.643, 09.672, 09.673, 
09.674, 09.831, 09.838, 09.855, 09.884, 09.885, 09.928, 09.937, 09.939 and 09.950]. The geometrical 
isomeric form is clear for 21 substances, [FL-no: 02.195, 02.234, 05.082, 05.217, 05.220, 05.226, 
09.567, 09.569, 09.572, 09.575, 09.638, 09.643, 09.672, 09.673, 09.674, 09.838, 09.855, 09.928, 
09.937, 09.939 and 09.950]. In the remaining 12 cases [FL-no: 02.152, 02.222, 05.061, 05.203, 05.218, 
08.074, 08.102, 09.377, 09.640, 09.831, 09.884 and 09.885], no indication has been given that one of 
the possible isomers has preponderance in the commercial flavouring material (see Table 1). For these 
flavouring substances [FL-no: 02.152, 02.222, 05.061, 05.203, 05.218, 08.074, 08.102, 09.377, 09.640, 
09.831, 09.884 and 09.885] Industry has informed that they exist as a “mixture of isomers” (EFFA, 
2010a) (see Table 1). However, the Panel does not consider this information sufficient and requests data 
on the actual ratios. 
1.3. Natural Occurrence in Food 
Thirty-seven candidate substances have been reported to occur naturally in meat, fruits, spices, herbs, 
mushrooms, licorice, vegetables, beer, beverage, cheese and/or butter, essential oils, tea, wine, cocoa, 
malt and cereals. (TNO, 2011). Quantitative data on the natural occurrence in food have been reported 
for 22 substances. These reports include among other: 
1.1 Candidate substances reported to occur in nature  (TNO, 2011) 
FL-no: Name: Quantitative data reported
02.175 2-Methylbut-3-en-1-ol up to 1.1 mg/kg in guava fruit 
02.176 3-Methylbut-3-en-1-ol 0.001 mg/kg in roasted chicken and up to 0.12 mg/kg in  
wine
05.203 9-Octadecenal 2 mg/kg in roasted chicken 
08.100 4-Methylpent-3-enoic acid 0.32 mg/kg in beer 
09.572 Hex-4-enyl acetate 1.56 mg/kg (Z-isomer) in banana 
09.928 trans-3-Hexenyl acetate 
up to 0.05 mg/kg in banana, up to 0.01 mg/kg in guava fruit, 
up to 0.005 mg/kg in mango and up to 0.01 mg/kg in 
passiflora 
09.937 Methyl (3Z)-hexenoate up to 0.25 mg/kg in guava fruit 
09.939 Ethyl (3Z)-hexenoate up to 0.15 mg/kg in passiflora juice 
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1.1 Candidate substances reported to occur in nature  (TNO, 2011) 
FL-no: Name: Quantitative data reported
09.950 (Z)-5-Octenyl acetate 0.05 mg/kg in banana 
 
According to the Flavour Industry, four candidate substances, oct-6-enal [FL-no: 05.061], 5-decenal 
[FL-no: 05.217], 16-octadecenal [FL-no: 05.218] and nona-3,6-dienyl acetate [FL-no: 09.674] in the 
present group are of artificial origin and have not been reported to occur naturally in foods (EFFA, 
2002d; EFFA, 2004u; Flavour Industry, 2008f). However, [FL-no: 05.217] has been reported by TNO 
(2011) to be in coriander leaf in trace amount and is included in the above 37 substances (TNO, 2011). 
According to TNO (2011) further 10 candidate substances have not been reported to occur naturally in 
any food items (TNO, 2011): 
1.2 Candidate substances not reported to occur in nature  (TNO, 2011) 
FL-no: Name: 
02.234 3-Nonen-1-ol 
05.220 4Z-Dodecenal 
05.226 E-4-Undecenal 
08.074 Dec-3-enoic acid 
09.838 3-Hexenyl methyl carbonate 
09.871 Citronellyl decanoate 
09.872 Citronellyl dodecanoate 
09.884 Hex-3-enyl-2-ethylbutyrate 
09.885 Hex-3-enyl hexadecanoate 
09.938 6-Methyl-5-hepten-2-yl acetate 
 
2. Specifications 
Purity criteria for the candidate substances have been provided by the Flavour Industry (EFFA, 2001c; 
EFFA, 2002b; EFFA, 2004u; EFFA, 2006c; EFFA, 2011a; Flavour Industry, 2004a; Flavour Industry, 
2008f; Flavour Industry, 2009w). 
Judged against the requirements in Annex II of Commission Regulation (EC) No 1565/2000 (EC, 
2000a), the purity criteria for 47 candidate substances are sufficient. For one substance [FL-no: 09.938] 
an ID test is missing and for two substances [FL-no: 05.226 and 09.950] the range of the specific 
gravity is too wide (more than 0.025). Information on composition of stereoisomeric mixture is needed 
for 12 substances [FL-no: 02.152, 02.222, 05.061, 05.203, 05.218, 08.074, 08.102, 09.377, 09.640, 
09.831, 09.884 and 09.885] (see Section 1.2 and Table 1).  
3. Intake Data 
Annual production volumes of the flavouring substances as surveyed by the Industry can be used to 
calculate the “Maximised Survey-derived Daily Intake” (MSDI) by assuming that the production figure 
only represents 60 % of the use in food due to underreporting and that 10 % of the total EU population 
are consumers (SCF, 1999a). 
However, the Panel noted that due to year-to-year variability in production volumes, to uncertainties in 
the underreporting correction factor and to uncertainties in the percentage of consumers, the reliability 
of intake estimates on the basis of the MSDI approach is difficult to assess. 
The Panel also noted that in contrast to the generally low per capita intake figures estimated on the 
basis of this MSDI approach, in some cases the regular consumption of products flavoured at use levels 
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reported by the Flavour Industry in the submissions would result in much higher intakes. In such cases, 
the human exposure thresholds below which exposures are not considered to present a safety concern 
might be exceeded. 
Considering that the MSDI model may underestimate the intake of flavouring substances by certain 
groups of consumers, the SCF recommended also taking into account the results of other intake 
assessments (SCF, 1999a). 
One of the alternatives is the “Theoretical Added Maximum Daily Intake” (TAMDI) approach, which is 
calculated on the basis of standard portions and upper use levels (SCF, 1995) for flavourable beverages 
and foods in general, with exceptional levels for particular foods. This method is regarded as a 
conservative estimate of the actual intake by most consumers because it is based on the assumption that 
the consumer regularly eats and drinks several food products containing the same flavouring substance 
at the upper use level. 
One option to modify the TAMDI approach is to base the calculation on normal rather than upper use 
levels of the flavouring substances. This modified approach is less conservative (e.g., it may 
underestimate the intake of consumers being loyal to products flavoured at the maximum use levels 
reported) (EC, 2000a). However, it is considered as a suitable tool to screen and prioritise the flavouring 
substances according to the need for refined intake data (EFSA, 2004a). 
3.1. Estimated Daily per Capita Intake (MSDI Approach) 
The intake estimation is based on the Maximised Survey-derived Daily Intake (MSDI) approach, which 
involves the acquisition of data on the amounts used in food as flavourings (SCF, 1999a). These data are 
derived from surveys on annual production volumes in Europe. These surveys were conducted in 1995 
by the International Organization of the Flavour Industry, in which flavour manufacturers reported the 
total amount of each flavouring substance incorporated into food sold in the EU during the previous 
year (IOFI, 1995). The intake approach does not consider the possible natural occurrence in food. 
Average per capita intake (MSDI) is estimated on the assumption that the amount added to food is 
consumed by 10 % of the population4 (Eurostat, 1998). This is derived for candidate substances from 
estimates of annual volume of production provided by Industry and incorporates a correction factor of 
0.6 to allow for incomplete reporting (60 %) in the Industry surveys (SCF, 1999a). 
In the present Flavouring Group Evaluation (FGE.06Rev3) the total annual volume of production of the 
candidate substances from use as flavouring substances in Europe has been reported to be approximately 
2200 kg (EFFA, 2001e; EFFA, 2002c; EFFA, 2004v; EFFA, 2006d; EFFA, 2008b; Flavour Industry, 
2004a; Flavour Industry, 2009w). For 65 of the 70 supporting substances the total annual volume of 
production is approximately 52000 kg (JECFA, 1999b; JECFA, 2000a; EFFA, 2002c). The annual 
volumes of production in Europe for five of the substances [FL-no: 02.110, 08.059, 09.141, 09.646 and 
09.927] were not reported. 
On the basis of the annual volume of production reported for the candidate substances, MSDI values for 
each of these flavourings have been estimated (Table 2a).  
About 94 % of the total annual volume of production for the candidate substances is accounted for by 
two flavourings methyl (3Z)-hexenoate [FL-no: 09.937] and ethyl (3Z)-hexenoate [FL-no: 09.939]. The 
estimated MSDI values of methyl (3Z)-hexenoate and of ethyl (3Z)-hexenoate from use as flavouring 
                                                     
 
4 EU figure 375 millions. This figure relates to EU population at the time for which production data are available, 
and is consistent (comparable) with evaluations conducted prior to the enlargement of the EU. No production data 
are available for the enlarged EU. 
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substances are 120 microgram/capita/day each. For all the remaining candidate substances the estimated 
daily per capita intakes are below 2 microgram (Table 2a). 
3.2. Intake Estimated on the Basis of the Modified TAMDI (mTAMDI) 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values is 
based on the approach used by SCF up to 1995 (SCF, 1995). 
The assumption is that a person may consume a certain amount of flavourable foods and beverages per 
day. 
For the present evaluation of the candidate substances, information on food categories and normal and 
maximum use levels5,6,7 were submitted by the Flavour Industry (EFFA, 2001e; EFFA, 2002a; EFFA, 
2004v; EFFA, 2006d; EFFA, 2007a; Flavour Industry, 2009w). No information on use levels have been 
submitted for nona-3,6-dienyl acetate [FL-no: 09.674]. For the remaining 49 candidate substances the 
use in flavoured food products divided into the food categories, outlined in Annex III of the 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), is shown in Table 3.1.  
For the present calculation of mTAMDI, the reported normal use levels were used. In the case where 
different normal use levels were reported for different food categories the highest reported normal use 
level was used. 
                                                     
 
5 ”Normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th percentile 
of reported usages (EFFA, 2002i). 
6 The normal and maximum use levels in different food categories (EC, 2000) have been extrapolated from figures 
derived from 12 model flavouring substances (EFFA, 2004e). 
7 The use levels from food category 5 “Confectionery” have been inserted as default values for food category 14.2 
“Alcoholic beverages” for substances for which no data have been given for food category 14.2 (EFFA, 2007a). 
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Table 3.1 Use of Candidate Substances in Various Food Categories for 49 Candidate Substances for 
which Data on Use have been provided 
Food 
category 
Description Flavourings used* 
01.0 Dairy products, excluding products of category 2 All except [FL-no: 02.125, 
05.226] 
02.0 Fats and oils, and fat emulsions (type water-in-oil) All except [FL-no: 02.125, 
05.220] 
03.0 Edible ices, including sherbet and sorbet All 
04.1 Processed fruits All except [FL-no: 02.125] 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses 
and legumes), and nuts & seeds 
Only [FL-no: 05.226, 09.928, 
09.937, 09.938, 09.939, 
09.950] 
05.0 Confectionery All  
06.0 Cereals and cereal products, incl. flours & starches from roots & 
tubers, pulses & legumes, excluding bakery 
All except [FL-no: 02.125, 
02.234] 
07.0 Bakery wares All except [FL-no: 02.125] 
08.0 Meat and meat products, including poultry and game All except [FL-no: 02.125, 
05.220, 09.950] 
09.0 Fish and fish products, including molluscs, crustaceans and 
echinoderms  
All except [FL-no: 02.125, 
05.220, 09.950] 
10.0 Eggs and egg products None 
11.0 Sweeteners, including honey Only [FL-no: 09.950] 
12.0 Salts, spices, soups, sauces, salads, protein products etc. All except [FL-no: 02.125, 
05.143, 05.220] 
13.0 Foodstuffs intended for particular nutritional uses All except [FL-no: 02.125, 
05.143, 05.220, 05.226, 
09.937, 09.938, 09.939, 
09.950] 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products All 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts All  
15.0 Ready-to-eat savouries All except [FL-no: 02.125, 
05.226] 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that 
could not be placed in categories 1 – 15 
All except [FL-no: 02.125, 
05.220, 05.226, 09.950] 
* No use levels have been submitted for [FL-no: 09.674] 
According to the Flavour Industry the normal use levels for the 49 candidate substances, for which 
Industry has provided data on food categories and normal and maximum use level are in the range of 
0.02 – 100 mg/kg food, and the maximum use levels are in the range of 0.08 to 500 mg/kg (EFFA, 
2001c; EFFA, 2002a; EFFA, 2004v; EFFA, 2006d; EFFA, 2007a; Flavour Industry, 2004a; Flavour 
Industry, 2009w). For nona-3,6-dienyl acetate [FL-no: 09.674] no use levels in the food categories as 
outlined in Annex III of Commission Regulation (EC) No 1565/2000 have been provided. 
The mTAMDI values for the 47 candidate substances from structural class I for which data have been 
provided (see Section 6) range from 36 to 40000 microgram/person/day. For the remaining two 
candidate substances from structural class II the mTAMDI is 1600 and 3900 microgram/person/day. 
For detailed information on use levels and intake estimations based on the mTAMDI approach, see 
Section 6 and Annex II. 
4. Absorption, Distribution, Metabolism and Elimination 
Specific information regarding absorption, distribution, metabolism and excretion is not available for 
any of the candidate substances. 
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The aliphatic alcohols, aldehydes and carboxylic acids in the present flavouring group are all expected 
to be absorbed from the gastrointestinal tract. Aliphatic esters are expected to be hydrolysed in the gut 
to yield the corresponding alcohols and carboxylic acids prior to absorption, or in the liver following 
absorption. 
In general, short chain (< C8) linear and branched-chain aliphatic esters, alcohols, aldehydes and 
carboxylic acids are rapidly absorbed from the gastrointestinal tract. Long-chain carboxylic acids, such 
as linoleic acid and oleic acid, are readily absorbed from micelles in the jejunum, re-esterified with 
glycerol in chylomicrons and transported via the lymphatic system.  
In vitro hydrolysis data from studies with esters structurally related to the candidate substances indicate 
that the esters included in this evaluation are hydrolysed to yield the corresponding alcohols and 
carboxylic acids in the gut prior to absorption or in the blood and liver following absorption.  
Candidate alcohols are oxidized to their corresponding carboxylic acids via aldehydes. Candidate 
aldehydes are oxidized to their corresponding carboxylic acids. In general, the carboxylic acids included 
in the present flavouring group or resulting from the hydrolysis of esters or oxidation of alcohols and 
aldehydes are expected to complete their metabolism in the fatty acid pathway or tricarboxylic acid 
cycle. 
Branched-chain carboxylic acids resulting from ester hydrolysis, alcohol or aldehyde oxidation may be 
metabolised via omega- and/or beta-oxidation to yield polar metabolites, which are excreted as such or 
as glucuronic acid conjugates, primarily in the urine. The two terpene alcohols resulting from the 
hydrolysis of five of the candidate esters included in the present flavouring group are expected to 
undergo omega-oxidation and excretion as such or after conjugation with glucuronic acid.  
The hydrolysis of the candidate substance hex-3-enyl 2-ethylbutyrate [FL-no: 09.884] generates 2-
ethylbutyric acid [FL-no: 08.045], which is resistant to beta-oxidation and has shown teratogenic 
potential (see Section 8.3). Although 2-ethylbutyric acid can be further conjugated with glucuronic acid 
or undergo omega-oxidation (see Annex III) the candidate substance [FL-no: 09.884] cannot be 
anticipated to be metabolised to innocuous products. 
Terminal double bonds appear in eleven candidate substances [FL-no: 02.125, 02.138, 02.170, 02.175, 
02.176, 02.201, 05.143, 05.174, 09.612, 09.897 and 09.898]. Of these, six are alcohols [FL-no: 02.125, 
02.138, 02.170, 02.175, 02.176 and 02.201], two are aldehydes [FL-no: 05.143 and 05.174], and three 
are esters [FL-no: 09.612, 09.897 and 09.898]. Although theoretically, these double bonds may be 
oxidised to give reactive epoxides, it is expected that for these candidate substances, the metabolism via 
this pathway is negligible. The terminal double bonds are all present in molecules that have alcohol- or 
aldehyde functions at the end distal from the double bond. The alcohol- and aldehyde functions are 
expected to be readily attacked by oxidation processes, ultimately yielding unsaturated carboxylic acids, 
and also hydrolysis of the esters would yield the unsaturated alcohols. Biochemical attack of these 
carboxylic acids via e.g. beta-oxidation or conjugation with glucuronic acid is expected to be much 
more efficient and rapid than microsomal oxidation. 
In summary, it is generally anticipated that the candidate esters will undergo hydrolysis in the 
gastrointestinal tract, blood and liver to yield their corresponding aliphatic alcohols and carboxylic 
acids. Alcohols and aldehydes are oxidised to the corresponding carboxylic acids. The carboxylic acids 
will proceed their metabolism in the fatty acid pathway, tricarboxylic acid cycle, or undergo further 
oxidation and excretion as such or after glucuronic acid conjugation. Except for one candidate 
substance, hex-3-enyl 2-ethylbutyrate [FL-no: 09.884], all the candidate substances can be anticipated to 
be metabolised to innocuous products. 
A more detailed discussion on hydrolysis of linear and branched-chain esters, metabolism of linear 
saturated/unsaturated primary alcohols, aldehydes and carboxylic acids, and branched-chain unsaturated 
primary alcohols, aldehydes and carboxylic acids follows in the Annex III. 
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5. Application of the Procedure for the Safety Evaluation of Flavouring Substances 
The application of the Procedure is based on intakes estimated on the basis of the MSDI approach. 
Where the mTAMDI approach indicates that the intake of a flavouring substance might exceed its 
corresponding threshold of concern, a formal safety assessment is not carried out using the Procedure. 
In these cases the Panel requires more precise data on use and use levels. For comparison of the intake 
estimations based on the MSDI approach and the mTAMDI approach, see Section 6. 
For the safety evaluation of the  candidate substances from chemical groups 1 and 4 the Procedure as 
outlined in Annex I was applied, based on the MSDI approach. The stepwise evaluations of the 
substances are summarised in Table 2a. 
Step 1 
All candidate substances are classified according to the decision tree approach by Cramer et al. (Cramer 
et al., 1978) into structural class I, except two ([FL-no: 05.143 and 09.884]), which are classified into 
structural class II. 
Step 2 
Step 2 requires consideration of the metabolism of the candidate substances.  
One substance, hex-3-enyl 2-ethylbutyrate [FL-no: 09.884], will be hydrolysed to give 2-ethylbutyric 
acid [FL-no: 08.045], which showed teratogenic potential in one mouse subcutaneous single-dose study, 
and is structurally related to valproic acid, which is a known teratogen (see Section 8.3). Although the 
hydrolysis product is expected to be metabolised e.g. via conjugation with glucuronic acid or omega 
oxidation, it cannot be excluded that adverse effects might be elicited, and therefore [FL-no: 09.884] 
proceeds via the B-side of the Procedure scheme (Annex I). 
The evaluation of the remaining 49 candidate substances proceeds via the A-side of the Procedure 
(Annex I) as they are expected to be metabolised into innocuous products. 
Step A3 
Forty-eight of the 49 candidate substances proceeding via the A-side have been assigned to structural 
class I and have estimated European daily per capita intakes (MSDI) ranging from 0.001 to 120 
microgram (Table 2a). These intakes are below the threshold of concern of 1800 microgram/person/day 
for structural class I. 
One of these 49 candidate substances proceeding via the A-side, [FL-no: 05.143], has been assigned to 
structural class II and has an estimated European daily per capita intake (MSDI) of 0.12 microgram 
(Table 2a). This intake is below the threshold of concern of 540 microgram/person/day for structural 
class II. 
For these 49 candidate substances the conditions of use do not result in an intake greater than the 
threshold of concern for the respective structural classes. 
Based on results of the safety evaluation sequence these 49 candidate substances proceeding via the A-
side of the Procedure do not pose a safety concern when used as flavouring substances at estimated 
levels of intake, based on the MSDI approach. 
Step B3 
This step is only relevant for [FL-no: 09.884] for which the estimated European daily per capita Intake 
(MSDI) is 0.58 microgram, which is far less than the threshold of concern for its structural class (i.e. 
540 microgram/person/day for class II). Accordingly, this candidate substance proceeds to step B4 of 
the Procedure. 
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Step B4 
The teratogenic activity of 2-ethylbutyric acid, a hydrolysis product of hex-3-enyl 2-ethylbutyrate [FL-
no: 09.884], has been described in a single-dose study after subcutaneous administration of 600 mg/kg 
body weight (bw) of 2-ethylbutyric acid to pregnant mice. Further, it should be taken into account that 
2-ethylbutyric acid is structurally related to valproic acid, which is a well-known teratogen. 
In a study in which 2-ethylbutyric acid was administered by gavage to pregnant rats once daily on 
gestation days 6 to 15, at dose levels of 0, 150, or 200 mg/kg bw/day, a NOAEL of 200 mg/kg bw/day 
for the teratogenic activity of 2-ethylbutyric acid could be derived.  
The estimated daily per capita intake (MSDI) of the candidate substance is 0.58 microgram 
corresponding to approximately 0.005 microgram 2-ethylbutyric acid/kg bw/day at a body weight of 60 
kg. This intake is more than 4 x 107 lower than the NOAEL for teratogenicity. 
Based on the results of the safety evaluation sequence (Annex I) this candidate substance [FL-no: 
09.884] does not pose a safety concern, including for teratogenicity, at the estimated level of intake, 
based on the MSDI approach. 
6. Comparison of the Intake Estimations Based on the MSDI Approach and the mTAMDI 
Approach 
The estimated intakes for 47 of the candidate substances in structural class I based on the mTAMDI 
range from 36 to 40000 microgram/person/day. For 10 of the substances [FL-no: 05.061, 05.082, 
05.174, 05.203, 05.217, 05.218, 05.220, 05.226, 09.937 and 09.939] the mTAMDI is below the 
threshold of concern of 1800 microgram/person/day. For 37 of the candidate substances from class I, the 
mTAMDI is above the threshold of concern. For one substance [FL-no: 09.674] no information on use 
levels have been provided. For comparison of the intake estimates based on the MSDI approach and the 
mTAMDI approach see Table 6.1. 
The estimated intakes of the two substances [FL-no: 05.143 and 09.884] assigned to structural class II, 
based on the mTAMDI are 1600 and 3900 microgram/person/day, respectively, which is above the 
threshold of concern for structural class II substances of 540 microgram/person/day. For comparison of 
the MSDI- and mTAMDI-values see Table 6.1. 
Thus, for 40 candidate substances further information is required. This would include more reliable 
intake data and where required additional toxicity data 
For comparison of the MSDI and mTAMDI values, see Table 6.1 
 
Table 6.1 Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no EU Register name MSDI 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
02.125 Undec-10-en-1-ol 0.37 2000 Class I 1800 
02.138 Dec-9-en-1-ol 0.15 3900 Class I 1800 
02.152 Hept-3-en-1-ol 0.012 3900 Class I 1800 
02.170 Lavandulol 0.012 3900 Class I 1800 
02.175 2-Methylbut-3-en-1-ol 1.4 3900 Class I 1800 
02.176 3-Methylbut-3-en-1-ol 0.13 3900 Class I 1800 
02.195 Octa-3,5-dien-1-ol 0.061 3900 Class I 1800 
02.201 Pent-4-en-1-ol 0.012 3900 Class I 1800 
02.222 3-Pentenol-1 0.5 3900 Class I 1800 
02.234 3-Nonen-1-ol 0.011 3900 Class I 1800 
05.061 Oct-6-enal 0.0012 1600 Class I 1800 
05.082 Dodeca-3,6-dienal 0.011 1600 Class I 1800 
05.174 Pent-4-enal 0.11 1600 Class I 1800 
05.203 9-Octadecenal 0.0097 1600 Class I 1800 
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05.217 5-Decenal 0.11 1600 Class I 1800 
05.218 16-Octadecenal 0.011 1600 Class I 1800 
05.220 4Z-Dodecenal 1.2 36 Class I 1800 
05.226 E-4-Undecenal 0.61 54 Class I 1800 
08.074 Dec-3-enoic acid 0.19 3200 Class I 1800 
08.100 4-Methylpent-3-enoic acid 1.8 3200 Class I 1800 
08.102 Non-3-enoic acid 0.011 3200 Class I 1800 
09.341 Citronellyl hexanoate 0.97 3900 Class I 1800 
09.368 Ethyl 4-methylpent-3-enoate 0.12 3900 Class I 1800 
09.377 Ethyl oct-3-enoate 0.35 3900 Class I 1800 
09.567 Hex-3-enyl decanoate 0.0024 3900 Class I 1800 
09.569 Hex-3-enyl octanoate 0.49 3900 Class I 1800 
09.572 Hex-4-enyl acetate 0.0012 3900 Class I 1800 
09.575 3-Hexenyl heptanoate 0.61 3900 Class I 1800 
09.612 Lavandulyl acetate 0.012 3900 Class I 1800 
09.638 Methyl dec-4-enoate 0.0012 3900 Class I 1800 
09.640 Methyl deca-4,8-dienoate 0.012 3900 Class I 1800 
09.643 Methyl geranate 0.95 3900 Class I 1800 
09.672 Non-3-enyl acetate 0.012 3900 Class I 1800 
09.673 Non-6-enyl acetate 0.12 3900 Class I 1800 
09.674 Nona-3,6-dienyl acetate 0.0024  Class I 1800 
09.831 Ethyl 3,7-dimethyl-2,6-octadienoate 0.61 3900 Class I 1800 
09.838 3-Hexenyl methyl carbonate 0.012 3900 Class I 1800 
09.855 trans-3-Hexenyl hexanoate 0.21 3900 Class I 1800 
09.871 Citronellyl decanoate 0.12 3900 Class I 1800 
09.872 Citronellyl dodecanoate 0.061 3900 Class I 1800 
09.885 Hex-3-enyl hexadecanoate 0.049 3900 Class I 1800 
09.897 3-Methylbut-3-en-1-yl butyrate 0.012 3900 Class I 1800 
09.898 3-Methylbut-3-en-1-yl hexanoate 0.012 3900 Class I 1800 
09.928 trans-3-Hexenyl acetate 1.8 3900 Class I 1800 
09.937 Methyl (3Z)-hexenoate 120 800 Class I 1800 
09.938 6-Methyl-5-hepten-2-yl acetate 1.2 40000 Class I 1800 
09.939 Ethyl (3Z)-hexenoate 120 800 Class I 1800 
09.950 Z-5-Octenyl acetate 0.61 7900 Class I 1800 
05.143 2,5-Dimethyl-2-vinylhex-4-enal 0.12 1600 Class II 540 
09.884 Hex-3-enyl-2-ethylbutyrate 0.58 3900 Class II 540 
7. Considerations of Combined Intakes from Use as Flavouring Substances 
Because of structural similarities of candidate and supporting substances, it can be anticipated that many 
of the flavourings are metabolised through the same metabolic pathways and that the metabolites may 
affect the same target organs. Further, in case of combined exposure to structurally related flavourings, 
the pathways could be overloaded. Therefore, combined intake should be considered. As flavourings not 
included in this FGE may also be metabolised through the same pathways, the combined intake 
estimates presented here are only preliminary. Currently, the combined intake estimates are only based 
on MSDI exposure estimates, although it is recognised that this may lead to underestimation of 
exposure. After completion of all FGEs, this issue should be readdressed. 
The total estimated combined daily per capita intake of structurally related flavourings is estimated by 
summing the MSDI for individual substances. On the basis of the reported annual volume of production 
in Europe (EFFA, 2001e; EFFA, 2002c; EFFA, 2004v; EFFA, 2006d; EFFA, 2008b; Flavour Industry, 
2004a; Flavour Industry, 2009w), the combined estimated daily per capita intake as flavouring of the 48 
candidate substances assigned to structural class I is approximately 260 microgram, which does not 
exceed the threshold of concern for the structural class of 1800 microgram/person/day. 
For the two candidate substances assigned to structural class II the combined estimated daily per capita 
intake is 0.7 microgram, which does not exceed the threshold of concern for structural class II of 540 
microgram/person/day. 
The candidate substance hex-3-enyl 2-ethylbutyrate [FL-no: 09.884] can be hydrolysed to the potential 
teratogenic substance 2-ethylbutyric acid (and hex-3-en-1-ol). No other candidate substances but one 
supporting substance, geranyl 2-ethylbutyrate [FL-no: 09.515], can be hydrolysed to 2-ethylbutyric acid 
(and geraniol). The estimated combined intake of these two substances corresponds to 0.5 microgram 2-
ethylbutyric acid/capita/day. This combined intake corresponds to 0.01 microgram 2-ethylbutyric 
acid/kg bw/day, which is more than 2 x 107 lower than the NOAEL of 200 mg/kg bw/day for 
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teratogenicity of 2-ethylbutyric acid in the rat (Narotsky et al., 1994). Therefore, it can be concluded 
that the combined intake of hex-3-enyl 2-ethylbutyrate [FL-no: 09.884] and geranyl 2-ethylbutyrate 
[FL-no: 09.515] does not pose a safety concern with respect to teratogenicity when used as flavouring 
substances at their estimated level of intakes, based on the MSDI approach. 
The candidate substances are structurally related to 70 supporting substances evaluated by the JEFCA at 
its 49th, 51st and 61st meeting (JECFA, 1998a; JECFA, 1999a; JECFA, 2004b). The production volumes 
of some of the 70 supporting substances were much higher than for the candidate substances. It was 
noted that the estimated combined intake (in Europe) is approximately 6400 microgram/capita/day for 
65 of the substances, all belonging to structural class I. The estimated levels of intake in Europe were 
not reported for five of the supporting substances [FL-no: 02.110, 08.059, 09.141, 09.646 and 09.927]. 
The total combined intake of the candidate and supporting substances is 6700 microgram/capita/day, 
which exceeds the threshold of concern for a compound belonging to structural class I. However, at the 
level of exposure resulting from the use as flavourings, all the candidate and supporting substances are 
expected to be efficiently metabolised and would not be expected to saturate the metabolic pathways. 
For these reasons and in the light of toxicological data on supporting substances (Annex IV), the total 
combined intake of these substances would not be expected to be of safety concern. 
8. Toxicity 
8.1. Acute Toxicity 
Data are available for four of the candidate substances and 42 supporting and structurally related 
substances. A few of these flavouring substances have oral LD50 values in mice and rats between 600 
and 3000 mg/kg body weight (bw) but most have LD50 values higher than 5000 mg/kg bw, indicating 
low oral acute toxicity of the candidate substances in the present group. 
The acute toxicity data are summarised in Annex IV, Table IV.1. 
8.2. Subacute, Subchronic, Chronic and Carcinogenicity Studies 
No subacute, subchronic, chronic nor carcinogenicity studies are available on the candidate substances.  
Twelve supporting substances were tested for subacute/subchronic toxicity and/or chronic toxicity, see 
Annex IV, Table IV.2.  
Three mouse carcinogenicity studies were performed with oleic acid [FL-no: 08.013] or oleic 
acid/linoleic acid mixture [FL-no: 08.013 / 08.041] (El-Khatib and Cora, 1981; Szepsenwol and 
Boschetti, 1975; Szepsenwol, 1978) and two carcinogenicity studies were performed with citronellyl 
acetate/geranyl acetate mixture [FL-no: 09.012 / 09.011] in mice and rats (NTP, 1987a).  
The Panel noted the data provided on oleic acid [FL-no: 08.013] as a supporting substance. The former 
EU Scientific Committee on Food allocated in 1991 an ADI “not specified” to fatty acids, including 
oleic acid (CEC, 1991). High intakes of fatty acids may stimulate tumour development in the gastro-
intestinal tract due to promoter activity, which can be considered as a threshold event (Zhang et al., 
1996; Reddy, 1995; Liu et al., 2001; Reddy, 1992). In addition, apart from aneuploidy (threshold 
genotoxic event), no other genotoxic effects with oleic acid were observed. The Panel concludes that the 
carcinogenicity of the oleic acid or linoleic acid/oleic acid mixture, if any, is not relevant with respect to 
assessment of the candidate substances in this group.  
A mixture of 29 % citronellyl acetate and 71 % geranyl acetate [FL-no: 09.012 / 09.011] was tested in 
rats and mice at dose levels of 0, 1000, and 2000 mg/kg bw/day (rats) or 0, 500 and 1000 mg/kg bw/day 
(mice) via gavage (NTP, 1987a). These studies showed an increase of kidney tubular cell adenomas in 
low dose male rats, 2/50 (4 %), but 0/50 in controls and highest dose male rats. For skin squamous cell 
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papillomas there was an increase 4/50 (8 %) in low dose male rats, but 0/50 in controls and 1/50 in 
highest dose male rats. The increased tumor incidence was observed in low dose male rats and not in 
mice and in female rats. The authors concluded that “under the conditions of these studies, geranyl 
acetate was not carcinogenic for F344/N rats or B6C3F1 mice of either sex; however, the reduced 
survival observed in high dose male rats, high dose male mice, and high and low dose female mice 
lowered the sensitivities of these studies for detecting neoplastic responses in these groups. In male rats 
the marginal increases of squamous cell papillomas of the skin and tubular cell adenomas of the kidney 
may have been related to administration of geranyl acetate” (NTP, 1987a). Further, geranyl acetate, the 
main component of the mixture tested, was not genotoxic in a set of in vitro and in vivo tests (see 
Section 8.4). There were no genotoxicity studies available on citronellyl acetate. 
 
The Panel concurs with the conclusions of the peer reviewed NTP study that geranyl acetate was not 
carcinogenic. 
Repeated dose toxicity data are summarised in Annex IV, Table IV.2. 
8.3. Developmental / Reproductive Toxicity Studies 
No adequate developmental and reproductive toxicity studies are available for any candidate substances 
for the present flavouring group evaluation (see Table IV.3).  
Two studies on developmental toxicity are available on a hydrolysis product, 2-ethylbutyric acid, of the 
candidate substance hex-3-enyl 2-ethylbutyrate [FL-no: 09.884]. Nau and Loescher (1986) studied 
valproic acid, and a number of metabolites of valproic acid, as well as other related substances including 
2-ethylbutyric acid [FL-no: 08.045]. The substances were tested with regard to their teratogenicity in 
mouse following single subcutaneous injections of 600 mg/kg on day 8 of gestation. Valproic acid as 
well as 4-en-valproic acid and a number of substances structurally related to valproic acid induced 
neural tube defects with an incidence from 0 % in controls, up to 61 % of live fetuses from mice treated 
with valproic acid (2 % of live fetuses for 2-ethylbutyric acid) (Nau and Löscher, 1986). The study 
demonstrates that teratogenicity varies significantly within the group of valproic acid metabolites and 
structurally related substances. 
Narotsky and co-workers (1994) studied the developmental effects of 2-ethylbutyric acid (and other 
aliphatic acids), administered by gavage to pregnant rats (Narotsky et al., 1994). Groups of pregnant 
Sprague-Dawley rats were given 0, 150 or 200 mg/kg bw/day of 2-ethylbutyric acid, on gestation days 6 
to 15. No developmental effects could be demonstrated. 
Developmental/reproductive toxicity data are summarised in Annex IV, Table IV.3. 
8.4. Genotoxicity Studies 
Experimental data are available for one candidate substance, methyl-3-but-3-en-1-ol [FL-no: 02.176], 
which was not mutagenic in the Ames test.  
There are data from in vitro genotoxicity tests for six supporting substances [FL-no: 05.074, 05.139, 
08.013, 09.011, 09.076, and 09.646]. The most extensively tested substances were oleic acid (six 
studies) and geranyl acetate (12 studies).  
Oleic acid [FL-no: 08.013] gave negative results when tested in in vitro tests for point mutations with 
both bacterial and mammalian cells as well as in a Rec assay. In the absence of exogenous metabolic 
activation, oleic acid induced chromosomal numerical abnormalities in Chinese hamster V79 cells, but 
no increase in sister-chromatid exchanges (SCE). The increase in chromosomal numerical 
abnormalities, although not dose-dependent, was observed at all concentration levels.  
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Geranyl acetate [FL-no: 09.011] was not mutagenic when tested in the Ames test. Negative results were 
also obtained in a Rec assay; moreover, it did not induce unscheduled DNA synthesis (UDS) in rat 
hepatocytes or chromosomal aberration in Chinese hamster ovary (CHO) cells, where it was also not 
able to inhibit DNA synthesis. Geranyl acetate gave weakly positive results in the SCE assay in CHO 
cells, although only at cytotoxic concentrations. In two poorly reported studies, it appeared weakly 
mutagenic at the TK locus in the mouse lymphoma assay in the presence of exogenous metabolic 
activation. In contrast, negative results were obtained in a valid, well-reported study on gene mutation at 
a TK6 locus in human lymphoblasts. 
All the remaining in vitro genotoxicity studies, performed with different supporting substances, gave 
negative results. 
The genotoxic potential of geranyl acetate [FL-no: 09.011] was assessed also in vivo: negative results 
were obtained in a micronucleus test in mice and in UDS induction in rats. Negative data on in vivo 
genotoxicity were also available for another supporting substance 2,6-dimethyl-5-heptanal [FL-no: 
05.074]. 
In summary, the validity of the weak positive results from the gene mutation assay performed with 
geranyl acetate is questionable, taking into account the negative results from other in vitro and in vivo 
assays. The reported induction of aneuploidy by oleic acid can be considered as a threshold event. All 
the remaining genotoxicity tests on supporting substances gave negative results. Data are available for 
one candidate substance, methyl-3-but-3-en-1-ol, which was not mutagenic in the Ames test. On this 
basis and on the results on supporting substances it can be concluded that genotoxicity is not of concern 
for the candidate substances in this FGE. 
Genotoxicity data are summaries in Annex IV, Table IV.4 and Table IV.5. 
9. Conclusions 
The 50 candidate substances are straight- and branched-chain unsaturated primary alcohols, aldehydes, 
carboxylic acids or esters and belong to chemical groups 1 or 4.  
Eight candidate substances possess a chiral centre [FL-no: 02.170, 02.175, 05.143, 09.341, 09.612, 
09.871, 09.872 and 09.938]. 
Thirty-three candidate substances can exist as geometrical isomers [FL-no: 02.152, 02.195, 02.222, 
02.234, 05.061, 05.082, 05.203, 05.217, 05.218, 05.220, 05.226, 08.074, 08.102, 09.377, 09.567, 
09.569, 09.572, 09.575, 09.638, 09.640, 09.643, 09.672, 09.673, 09.674, 09.831, 09.838, 09.855, 
09.884, 09.885, 09.928, 09.937, 09.939 and 09.950]. For 12 of these substances [FL-no: 02.152, 02.222, 
05.061, 05.203, 05.218, 08.074, 08.102, 09.377, 09.640, 09.831, 09.884 and 09.885] have the 
stereoisomeric mixture not been specified sufficiently.  
Forty-eight candidate substances are classified into structural class I. The remaining two substances 
[FL-no: 05.143 and 09.884] are classified into structural class II. 
Thirty-seven of the flavouring substances in the present group have been reported to occur naturally in a 
wide range of food items. 
According to the default MSDI approach, the flavouring substances in this group have intakes in Europe 
from 0.0012 to 120 microgram/capita/day, which are below the thresholds of concern value for both 
structural class I (1800 microgram/person/day) and structural class II (540 microgram/person/day) 
substances.  
On the basis of the reported annual production volumes in Europe (MSDI approach), the combined 
intake of the 48 candidate substances belonging to structural class I and of the two candidate substances 
Flavouring Group Evaluation 06, Revision 3 
 
 
19 EFSA Journal 2011; 9(11):2397 
belonging to structural class II would result in a total intake of approximately 260 and 0.7 
microgram/capita/day, respectively. These values are below the thresholds of concern for structural 
class I and class II substances of 1800 and 540 microgram/person/day, respectively. The total combined 
estimated intake of 65 of the 70 supporting substances for which European annual production data are 
available and of the 48 candidate substances from structural class I is approximately 6700 
microgram/capita/day, which exceeds the threshold of concern for structural class I (1800 
microgram/person/day). However, the substances are expected to be efficiently metabolised and are not 
expected to saturate the metabolic pathways. 
For the substances in this group the limited data available do not give rise to safety concern with respect 
to genotoxicity and carcinogenicity.  
Except for hex-3-enyl 2-ethylbutyrate [FL-no: 09.884] the candidate substances are expected to be 
metabolised to innocuous substances at the estimated levels of use as flavouring substances. One of the 
hydrolysis products of [FL-no: 09.884], 2-ethylbutyric acid, showed teratogenic potential in one mouse 
subcutaneous single-dose study, and is structurally related to valproic acid, which is a known teratogen. 
However, an additional study in which 2-ethylbutyric acid was given by gavage to pregnant rats showed 
a NOAEL of 200 mg/kg bw/day of 2-ethylbutyric acid. This dose is more than 4 x 107 times higher than 
the MSDI for 2-ethylbutyric acid arising from the intake of the candidate substance, [FL-no: 09.884]. 
Accordingly, the candidate substance [FL-no: 09.884] does not pose a safety concern with respect to 
teratogenicity when used at the level of intake as flavouring substance estimated on the basis of the 
MSDI approach. 
 
It was noted that where toxicity data were available they were consistent with the conclusions in the 
present flavouring group evaluation using the Procedure. 
It is considered that on the basis of the default MSDI approach the candidate substances would not give 
rise to safety concerns at the estimated levels of intake arising from their use as flavouring substances. 
When the estimated intakes were based on the mTAMDI approach they ranged from 36 to 40000 
microgram/person/day for the 47 flavouring substances from structural class I for which data have been 
provided. The intakes were all above the threshold of concern for structural class I of 1800 
microgram/person/day, except for 10 flavouring substances [FL-no: 05.061, 05.082, 05.174, 05.203, 
05.217, 05.218, 05.220, 05.226, 09.937 and 09.939]. The estimated intakes of the two flavouring 
substances assigned to structural class II, based on the mTAMDI are 1600 and 3900 
microgram/person/day, which is above the threshold of concern for structural class II of 540 
microgram/person/day. The 10 substances [FL-no: 05.061, 05.082, 05.174, 05.203, 05.217, 05.218, 
05.220, 05.226, 09.937 and 09.939], which have mTAMDI intake estimates below the threshold of 
concern for structural class I, are also expected to be metabolised to innocuous products.  
Thus, for 39 flavouring substances considered in this Opinion, the intakes, estimated on the basis of the 
mTAMDI, exceed the relevant threshold for their structural class, to which the flavouring substance has 
been assigned. For one substance [FL-no: 09.647] no use levels were provided. Therefore, for these 40 
substances more reliable exposure data are required. On the basis of such additional data, these 
flavouring substances should be reconsidered along the steps of the Procedure. Subsequently, additional 
data might become necessary.  
In order to determine whether the conclusion for the candidate substances can be applied to the material 
of commerce, it is necessary to consider the available specifications. Specifications including complete 
purity criteria and identity for the materials of commerce have been provided for 47 flavouring 
candidate substances. For one substance [FL-no: 09.938] an identity test is missing and for two 
substances [FL-no: 05.226 and 09.950] the range of the specific gravity is too wide (more than 0.025). 
Additional, the composition of the stereoisomeric mixture has not been specified sufficiently for 12 
substances [FL-no: 02.152, 02.222, 05.061, 05.203, 05.218, 08.074, 08.102, 09.377, 09.640, 09.831, 
09.884 and 09.885]. 
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The final evaluation of the materials of commerce cannot be performed for 15 substances [FL-no: 
02.152, 02.222, 05.061, 05.203, 05.218, 05.226, 08.074, 08.102, 09.377, 09.640, 09.831, 09.884, 
09.885, 09.938 and 09.950], pending further information. The remaining 35 substances [FL-no: 02.125, 
02.138, 02.170, 02.175, 02.176, 02.195, 02.201, 02.234, 05.082, 05.143, 05.174, 05.217, 05.220, 
08.100, 09.341, 09.368, 09.567, 09.569, 09.572, 09.575, 09.612, 09.638, 09.643, 09.672, 09.673, 
09.674, 09.838, 09.855, 09.871, 09.872, 09.897, 09.898, 09.928, 09.937 and 09.939] would present no 
safety concern at the levels of intake estimated on the basis of the MSDI approach.                
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TABLE 1: SPECIFICATION SUMMARY OF THE SUBSTANCES IN THE FLAVOURING GROUP EVALUATION 06, REVISION 3 
Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 06, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
02.125 
 
Undec-10-en-1-ol OH   
10319 
112-43-6 
Liquid 
C11H22O 
170.29 
Practically insoluble 
or insoluble 
Freely soluble 
245-248 
 
MS 
95 % 
1.445-1.451 
0.845-0.851 
 
 
02.138 
 
Dec-9-en-1-ol OH   
 
13019-22-2 
Liquid 
C10H20O 
156.27 
Practically insoluble 
or insoluble 
Freely soluble 
86 (3 hPa) 
 
MS 
95 % 
1.445-1.451 
0.842-0.848 
 
 
02.152 
 
Hept-3-en-1-ol OH
(E)-isomer shown  
 
10219 
10606-47-0 
Liquid 
C7H14O 
114.19 
Practically insoluble 
or insoluble 
Freely soluble 
80 (27 hPa) 
 
MS 
95 % 
1.439-1.445 
0.848-0.854 
 
Mixture of (Z)- and (E)-
isomers (EFFA, 2010a). 
Composition of 
stereoisomeric mixture to be 
specified. 
02.170 
 
Lavandulol 
OH
 
 
498-16-8 
Liquid 
C10H18O 
154.25 
Practically insoluble 
or insoluble 
Freely soluble 
78 (7 hPa) 
 
MS 
95 % 
1.467-1.473 
0.877-0.883 
 
Register name to be changed 
to (R)-(-)-Lavandulol. 
02.175 
 
2-Methylbut-3-en-1-ol OH
 
 
10259 
4516-90-9 
Liquid 
C5H10O 
86.13 
Sparingly soluble 
Freely soluble 
122 
 
MS 
95 % 
1.421-1.427 
0.841-0.847 
 
Racemate (EFFA, 2010a). 
02.176 
 
3-Methylbut-3-en-1-ol OH
 
 
10260 
763-32-6 
Liquid 
C5H10O 
86.13 
Sparingly soluble 
Freely soluble 
130 
 
MS 
95 % 
1.431-1.437 
0.850-0.856 
 
 
02.195 
 
Octa-3,5-dien-1-ol OH   
 
70664-96-9 
Liquid 
C8H14O 
126.20 
Practically insoluble 
or insoluble 
Freely soluble 
90 (24 hPa) 
 
NMR 
95 % 
1.457-1.463 
0.865-0.871 
 
Register name to be changed 
to Octa-(3Z,5E)-dien-1-ol. 
02.201 
 
Pent-4-en-1-ol OH   
 
821-09-0 
Liquid 
C5H10O 
86.13 
Sparingly soluble 
Freely soluble 
137 
 
MS 
95 % 
1.427-1.433 
0.843-0.849 
 
 
02.222 
 
3-Pentenol-1 OH
E-isomer shown  
 
10298 
39161-19-8 
Liquid 
C5H10O 
86.13 
Sparingly soluble 
Freely soluble 
134 
 
MS 
95 % 
1.432-1.438 
0.846-0.852 
 
Mixture of (Z)- and (E)-
isomers (EFFA, 2010a). 
Composition of 
stereoisomeric mixture to be 
specified. 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 06, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
02.234 
 
3-Nonen-1-ol OH  4412 
10293 
10340-23-5 
Liquid 
C9H18O 
142.24 
Practically insoluble 
or insoluble 
Freely soluble 
115 (33 hPa) 
 
MS 
95 % 
1.452-1.458 
0.862-0.868 
 
Register name to be changed 
to (3Z)-Nonen-1-ol (EFFA, 
2010a). 
 
05.061 
 
Oct-6-enal O
(E)- isomer shown  
 
664 
63826-25-5 
Liquid 
C8H14O 
126.20 
Practically insoluble 
or insoluble 
Freely soluble 
87 (67 hPa) 
 
NMR 
95 % 
1.433-1.439 
0.842-0.848 
 
Mixture of (Z)- and (E)-
isomers (EFFA, 2010a). 
Composition of 
stereoisomeric mixture to be 
specified. 
05.082 
 
Dodeca-3,6-dienal O   
2121 
13553-09-8 
Liquid 
C12H20O 
180.24 
Practically insoluble 
or insoluble 
Freely soluble 
226 
 
MS 
95 % 
1.440-1.446 
0.844-0.850 
 
Register name to be changed 
to Dodeca-(3Z,6Z)-dienal 
(EFFA, 2010a). 
 
05.143 
 
2,5-Dimethyl-2-vinylhex-4-enal O
 
 
 
56134-05-5 
Liquid 
C10H16O 
152.24 
Sparingly soluble 
Freely soluble 
72 (16 hPa) 
 
MS 
95 % 
1.452-1.458 
0.845-0.851 
 
Racemate (EFFA, 2010a). 
05.174 
1619 
Pent-4-enal O   
 
2100-17-6 
Liquid 
C5H8O 
84.12 
Slightly soluble 
Freely soluble 
103 
 
MS 
95 % 
1.413-1.420 
0.849-0.855 
 
 
05.203 
1641 
9-Octadecenal O   
 
5090-41-5 
Liquid 
C18H34O 
266.47 
Practically insoluble 
or insoluble 
Freely soluble 
168 (5 hPa) 
 
MS 
95 % 
1.455-1.461 
0.848-0.854 
 
Mixture of (Z)- and (E)-
isomers (EFFA, 2010a). 
Composition of 
stereoisomeric mixture to be 
specified. 
05.217 
 
5-Decenal O   
 
21662-08-8 
Liquid 
C10H18O 
154.25 
Practically insoluble 
or insoluble 
Freely soluble 
92 (3 hPa) 
 
MS 
95 % 
1.441-1.447 
0.842-0.848 
 
Register name to be changed 
to (5Z)-Decenal (EFFA, 
2010a). 
 
05.218 
 
16-Octadecenal 
O  
 
 
56554-87-1 
Solid 
C18H34O 
266.46 
Practically insoluble 
or insoluble 
Freely soluble 
391 
56 
MS 
95 % 
n.a. 
n.a. 
 
Mixture of (Z)- and (E)-
isomers (EFFA, 2010a). 
Composition of 
stereoisomeric mixture to be 
specified. 
05.220 
1636 
4Z-Dodecenal O  4036 
 
21944-98-9 
Liquid 
C12H22O 
182.30 
Slightly soluble 
Very soluble 
254 
n.a. 
IR NMR MS 
1.443-1.449 
0.843-0.849 
 
Known imputities: 1.06 % 
4E-dodecenal, 3.66 % 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 06, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
94 % dodecanal (FL-no: 05.011), 
1.29 % tetradecane (FL-no: 
01.057). 
05.226 
 
E-4-Undecenal O  4672 
 
68820-35-9 
Liquid 
C11H20O 
168.15 
Insoluble 
Soluble 
237.2 +/- 9.0 
 
IR 
> 95% 
1.4410-
1.4511 
0.777-0.897 
 
 
08.074 
 
Dec-3-enoic acid 
OH
O
E-isomer shown  
 
10088 
15469-77-9 
Liquid 
C10H18O2 
170.25 
Practically insoluble 
or insoluble 
Freely soluble 
158 
 
MS 
95 % 
1.437-1.457 
0.933-0.939 
 
Mixture of (Z)- and (E)-
isomers (EFFA, 2010a). 
Composition of 
stereoisomeric mixture to be 
specified. 
08.100 
 
4-Methylpent-3-enoic acid 
OH
O
 
 
 
504-85-8 
Liquid 
C6H10O2 
114.14 
Sparingly soluble 
Freely soluble 
99 (13 hPa) 
 
MS 
95 % 
1.443-1.449 
0.973-0.979 
 
 
08.102 
 
Non-3-enoic acid 
O
OH
 
 
10154 
4124-88-3 
Liquid 
 
156.22 
Very slightly soluble 
Freely soluble 
158 (24 hPa) 
 
MS 
95 % 
1.445-1.451 
0.925-.0931 
 
Mixture of (Z)- and (E)-
isomers (EFFA, 2010a). 
Composition of 
stereoisomeric mixture to be 
specified. 
09.341 
 
Citronellyl hexanoate 
O
O
 
 
 
10580-25-3 
Liquid 
C16H30O2 
254.41 
Practically insoluble 
or insoluble 
Freely soluble 
240 
 
MS 
95 % 
1.446-1.450 
0.871-0.876 
 
Racemate (EFFA, 2010a). 
09.368 
 
Ethyl 4-methylpent-3-enoate 
O
O
 
 
10615 
6849-18-9 
Liquid 
C8H14O2 
142.20 
Practically insoluble 
or insoluble 
Freely soluble 
66 (23 hPa) 
 
MS 
95 % 
1.427-1.433 
0.910-0.916 
 
 
09.377 
1632 
Ethyl oct-3-enoate 
O
O
E-isomer shown  
4361 
10618 
1117-65-3 
Liquid 
C10H18O2 
170.25 
Practically insoluble 
or insoluble 
Freely soluble 
94 (13 hPa) 
 
MS 
95 % 
1.431-1.439 
0.903-0.910 
 
Mixture of (Z)- and (E)-
isomers (EFFA, 2010a). 
Composition of 
stereoisomeric mixture to be 
specified. 
09.567 
 
Hex-3-enyl decanoate 
O
O
 
 
 
85554-69-4 
Liquid 
C16H30O2 
254.41 
Practically insoluble 
or insoluble 
Freely soluble 
315 
 
MS 
95 % 
1.439-1.445 
0.875-0.881 
 
Register name to be changed 
to Hex-(3Z)-enyl decanoate. 
09.569 
 
Hex-3-enyl octanoate 
O
O
 
 
 
61444-41-5 
Liquid 
C14H26O2 
226.36 
Practically insoluble 
or insoluble 
Freely soluble 
286 
 
MS 
1.431-1.451 
0.878-0.884 
 
Register name to be changed 
to Hex-(3Z)-enyl octanoate. 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 06, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
95 % 
09.572 
 
Hex-4-enyl acetate 
O
O
 
 
 
42125-17-7 
Liquid 
C8H14O2 
142.20 
Practically insoluble 
or insoluble 
Freely soluble 
73 (27 hPa) 
 
MS 
95 % 
1.426-1.432 
0.900-0.906 
 
Register name to be changed 
to Hex-(4Z)-enyl acetate. 
09.575 
 
3-Hexenyl heptanoate 
O
O
 
 
 
61444-39-1 
Liquid 
C13H24O2 
212.33 
Practically insoluble 
or insoluble 
Freely soluble 
270 
 
MS 
95 % 
1.433-1.439 
0.880-0.886 
 
Register name to be changed 
to (3Z)-Hexenyl heptanoate. 
09.612 
 
Lavandulyl acetate 
O
O
 
 
25905-14-0 
Liquid 
C12H20O2 
196.29 
Practically insoluble 
or insoluble 
Freely soluble 
100 (15 hPa) 
 
MS 
95 % 
1.453-1.459 
0.909-0.915 
 
Racemate (EFFA, 2010a). 
09.638 
 
Methyl dec-4-enoate 
O
O
 
 
10784 
7367-83-1 
Liquid 
C11H20O2 
184.28 
Practically insoluble 
or insoluble 
Freely soluble 
112 (20 hPa) 
 
MS 
95 % 
1.438-1.444 
0.891-0.897 
 
Register name to be changed 
to Methyl dec-(4Z)-enoate. 
09.640 
 
Methyl deca-4,8-dienoate 
O
O
(4E, 8E)-isomer shown  
 
10782 
1191-03-3 
Liquid 
C11H18O2 
182.26 
Practically insoluble 
or insoluble 
Freely soluble 
241 
 
NMR 
95 % 
1.443-1.449 
0.904-0.910 
 
Mixture of 
(E,E)/(E,Z)/(Z,E)/(Z,Z) 
(EFFA, 2010a). 
Composition of 
stereoisomeric mixture to be 
specified. 
09.643 
 
Methyl geranate O
O
 
10797 
1189-09-9 
Liquid 
C11H18O2 
182.26 
Insoluble 
Freely soluble 
97 (13 hPa) 
 
MS 
95 % 
1.465-1.471 
0.916-0.925 
 
 
09.672 
 
Non-3-enyl acetate 
O
O
 
 
 
13049-88-2 
Liquid 
C11H20O2 
184.28 
Practically insoluble 
or insoluble 
Freely soluble 
61 (0.1 hPa) 
 
MS 
95 % 
1.429-1.435 
0.886-0.892 
 
Register name to be changed 
to Non-(3Z)-enyl acetate. 
09.673 
 
Non-6-enyl acetate 
O
O
 
 
 
76238-22-7 
Liquid 
C11H20O2 
184.28 
Practically insoluble 
or insoluble 
Freely soluble 
90 (4 hPa) 
 
MS 
95 % 
1.432-1.438 
0.886-0.892 
 
Register name to be changed 
to Non-(6Z)-enyl acetate. 
09.674 
1285 
Nona-3,6-dienyl acetate 
O
O
 
 
 
76649-26-8 
Liquid 
C11H18O2 
182.26 
Insoluble 
Soluble 
75 (20hPa) 
 
MS 
95% 
1.448-1.454 
0.898-0.905 
 
(Z)- or (E)-isomer not 
specified by CASrn in 
Register. CASrn to be 
changed to 211323-05-6 
(correspond to JECFA-no 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 06, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
1285) and name to (E;Z)-
3,6-Nonadien-1-ol, acetate 
(EFFA, 2011a). 
09.831 
 
Ethyl 3,7-dimethyl-2,6-
octadienoate 
O
O
E-isomer shown
 
 
13058-12-3 
Liquid 
C12H20O2 
196.29 
Practically insoluble 
or insoluble 
Freely soluble 
114 (13 hPa) 
 
MS 
95 % 
1.463-1.469 
0.911-0.917 
 
Mixture of (Z)- and (E)-
isomers (EFFA, 2010a). 
Composition of 
stereoisomeric mixture to be 
specified. 
09.838 
 
3-Hexenyl methyl carbonate 
O O
O
 
 
 
67633-96-9 
Liquid 
C8H14O3 
158.19 
Slightly soluble 
Freely soluble 
78 (4 hPa) 
 
MS 
98 % 
1.426-1.430 
0.966-0.971 
 
Register name to be changed 
(3Z)-Hexenyl methyl 
carbonate. 
09.855 
 
trans-3-Hexenyl hexanoate 
O
O
 
 
 
56922-82-8 
Liquid 
C12H22O2 
198.30 
Practically insoluble 
or insoluble 
Freely soluble 
253 
 
MS 
95 % 
1.428-1.434 
0.883-0.889 
 
 
09.871 
 
Citronellyl decanoate 
O
O
 
 
 
72934-06-6 
Liquid 
C20H38O2 
310.52 
Practically insoluble 
or insoluble 
Freely soluble 
202 (13 hPa) 
 
NMR 
95 % 
1.448-1.454 
0.869-0.875 
 
Racemate (EFFA, 2010a). 
09.872 
 
Citronellyl dodecanoate 
O
O
 
 
 
72934-07-7 
Liquid 
C22H42O2 
338.57 
Practically insoluble 
or insoluble 
Freely soluble 
217 (13 hPa) 
 
NMR 
95 % 
1.450-1.456 
0.867-0.873 
 
Racemate (EFFA, 2010a). 
09.884 
 
Hex-3-enyl-2-ethylbutyrate 
O
O
E-isomer shown  
 
 
233666-04-1 
Liquid 
C12H22O2 
198.30 
Practically insoluble 
or insoluble 
Freely soluble 
243 
 
NMR 
95 % 
1.426-1.432 
0.881-0.887 
 
Mixture of (Z)- and (E)-
isomers (EFFA, 2010a). 
Composition of 
stereoisomeric mixture to be 
specified. 
09.885 
 
Hex-3-enyl hexadecanoate 
O
O
E-isomer shown
 
 
233666-03-0 
Liquid 
C22H42O2 
338.57 
Practically insoluble 
or insoluble 
Freely soluble 
387 
 
NMR 
95 % 
1.454-1.460 
0.867-0.873 
 
Mixture of (Z)- and (E)-
isomers (EFFA, 2010a). 
Composition of 
stereoisomeric mixture to be 
specified. 
09.897 
 
3-Methylbut-3-en-1-yl butyrate 
O
O
 
 
 
54702-13-5 
Liquid 
C9H16O2 
156.22 
Practically insoluble 
or insoluble 
Freely soluble 
184 
 
MS 
95 % 
1.439-1.445 
0.886-0.892 
 
 
09.898 
 
3-Methylbut-3-en-1-yl hexanoate 
O
O
 
 
 
53655-22-4 
Liquid 
C11H20O2 
184.28 
Practically insoluble 
or insoluble 
Freely soluble 
223 
 
MS 
1.453-1.458 
0.877-0.883 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 06, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
95 % 
09.928 
 
trans-3-Hexenyl acetate O
O  
4413 
 
3681-82-1 
Liquid 
C8H14O2 
142.20 
Practically insoluble 
or insoluble 
Freely soluble 
201 
 
MS 
97 % 
1.420-1.426 
0.893-0.899 
 
 
09.937 
1624 
Methyl (3Z)-hexenoate 
O
O
 
 
 
13894-62-7 
Liquid 
C7H12O2 
128.17 
Sparingly soluble 
Soluble 
85 (107 hPa) 
 
MS 
> 95 % 
1.422-1.430 
0.914-0.924 
 
 
09.938 
1838 
6-Methyl-5-hepten-2-yl acetate O
O  
4177 
 
19162-00-6 
Liquid 
C10H18O2 
170.25 
Insoluble 
Soluble 
184 
 
 
> 97 % 
1.420-1.429 
0.893-0.903 
ID 6). 
Racemate (EFFA, 2010a). 
09.939 
1626 
Ethyl (3Z)-hexenoate 
O
O
 
4112 
 
64187-83-3 
Liquid 
C8H14O2 
142.20 
Sparingly soluble 
Soluble 
90 (67 hPa) 
 
MS 
> 96 % 
1.420-1.429 
0.893-0.903 
 
 
09.950 
 
Z-5-Octenyl acetate 
O
O 4671 
 
71978-00-2 
Liquid 
C10H18O2 
170.13 
Insoluble 
Soluble 
226.2 +/- 19.0 
 
IR 
> 95% 
1.4301-
1.4401 
0.832-0.952 
 
 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 %  ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
6) ID: Missing identification test. 
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TABLE 2A: SUMMARY OF SAFETY EVALUATION APPLYING THE PROCEDURE (BASED ON INTAKES CALCULATED BY THE MSDI APPROACH) 
Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
02.125 
 
Undec-10-en-1-ol OH  0.37 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.138 
 
Dec-9-en-1-ol OH  0.15 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.152 
 
Hept-3-en-1-ol OH
(E)-isomer shown
0.012 
 
Class I 
A3: Intake below threshold 
4) 7)  
02.170 
 
Lavandulol 
OH
0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.175 
 
2-Methylbut-3-en-1-ol OH 1.4 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.176 
 
3-Methylbut-3-en-1-ol OH 0.13 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.195 
 
Octa-3,5-dien-1-ol OH  0.061 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.201 
 
Pent-4-en-1-ol OH  0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.222 
 
3-Pentenol-1 OH
E-isomer shown
0.5 
 
Class I 
A3: Intake below threshold 
4) 7)  
02.234 
 
3-Nonen-1-ol OH  0.011 
 
Class I 
A3: Intake below threshold 
4) 6)  
05.061 
 
Oct-6-enal O
(E)- isomer shown
0.0012 
 
Class I 
A3: Intake below threshold 
4) 7)  
05.082 
 
Dodeca-3,6-dienal O  0.011 
 
Class I 
A3: Intake below threshold 
4) 6)  
05.174 
1619 
Pent-4-enal O  0.11 
 
Class I 
A3: Intake below threshold 
4) 6)  
05.203 
1641 
9-Octadecenal O  0.0097 
 
Class I 
A3: Intake below threshold 
4) 7)  
05.217 
 
5-Decenal O  0.11 
 
Class I 
A3: Intake below threshold 
4) 6)  
05.218 
 
16-Octadecenal 
O
0.011 
 
Class I 
A3: Intake below threshold 
4) 7)  
05.220 
1636 
4Z-Dodecenal O  1.2 
 
Class I 
A3: Intake below threshold 
4) 6)  
05.226 
 
E-4-Undecenal O  0.61 
 
Class I 
A3: Intake below threshold 
4) 7)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
08.074 
 
Dec-3-enoic acid 
OH
O
E-isomer shown
0.19 
 
Class I 
A3: Intake below threshold 
4) 7)  
08.100 
 
4-Methylpent-3-enoic acid 
OH
O 1.8 
 
Class I 
A3: Intake below threshold 
4) 6)  
08.102 
 
Non-3-enoic acid 
O
OH 0.011 
 
Class I 
A3: Intake below threshold 
4) 7)  
09.341 
 
Citronellyl hexanoate 
O
O 0.97 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.368 
 
Ethyl 4-methylpent-3-enoate 
O
O 0.12 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.377 
1632 
Ethyl oct-3-enoate 
O
O
E-isomer shown
0.35 
 
Class I 
A3: Intake below threshold 
4) 7)  
09.567 
 
Hex-3-enyl decanoate 
O
O 0.0024 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.569 
 
Hex-3-enyl octanoate 
O
O 0.49 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.572 
 
Hex-4-enyl acetate 
O
O 0.0012 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.575 
 
3-Hexenyl heptanoate 
O
O 0.61 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.612 
 
Lavandulyl acetate 
O
O
0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.638 
 
Methyl dec-4-enoate 
O
O 0.0012 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.640 
 
Methyl deca-4,8-dienoate 
O
O
(4E, 8E)-isomer shown
0.012 
 
Class I 
A3: Intake below threshold 
4) 7)  
09.643 
 
Methyl geranate O
O
0.95 
 
Class I 
A3: Intake below threshold 
4) 6)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
09.672 
 
Non-3-enyl acetate 
O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.673 
 
Non-6-enyl acetate 
O
O 0.12 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.674 
1285 
Nona-3,6-dienyl acetate 
O
O 0.0024 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.831 
 
Ethyl 3,7-dimethyl-2,6-
octadienoate 
O
O
E-isomer shown
0.61 
 
Class I 
A3: Intake below threshold 
4) 7)  
09.838 
 
3-Hexenyl methyl carbonate 
O O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.855 
 
trans-3-Hexenyl hexanoate 
O
O 0.21 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.871 
 
Citronellyl decanoate 
O
O 0.12 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.872 
 
Citronellyl dodecanoate 
O
O 0.061 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.885 
 
Hex-3-enyl hexadecanoate 
O
O
E-isomer shown
0.049 
 
Class I 
A3: Intake below threshold 
4) 7)  
09.897 
 
3-Methylbut-3-en-1-yl butyrate 
O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.898 
 
3-Methylbut-3-en-1-yl hexanoate 
O
O 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.928 
 
trans-3-Hexenyl acetate O
O
1.8 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.937 
1624 
Methyl (3Z)-hexenoate 
O
O 120 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.938 
1838 
6-Methyl-5-hepten-2-yl acetate O
O
1.2 
 
Class I 
A3: Intake below threshold 
4) 7)  
09.939 
1626 
Ethyl (3Z)-hexenoate 
O
O 120 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.950 
 
Z-5-Octenyl acetate 
O
O 0.61 
 
Class I 
A3: Intake below threshold 
4) 7)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
05.143 
 
2,5-Dimethyl-2-vinylhex-4-enal O 0.12 
 
Class II 
A3: Intake below threshold 
4) 6)  
09.884 
 
Hex-3-enyl-2-ethylbutyrate 
O
O
E-isomer shown
0.58 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 7)  
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
6) No safety concern at estimated level of intake of the material of commerce meeting the specification of Table 1 (based on intake calculated by the MSDI approach). 
7) Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or information on stereoisomerism. 
8) No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
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TABLE 2B: EVALUATION STATUS OF HYDROLYSIS PRODUCTS OF CANDIDATE ESTERS  
Table 2b: Evaluation Status of Hydrolysis Products of Candidate Esters 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
 Methanol 
CH4O 
32.04 
H
H
H
OH
 
Not evaluated as flavouring substance  Not in EU-Register. 
 Hex-3(trans)-en-1-ol OH  Not evaluated as flavouring substance  
 
 
Not in EU-Register (former [FL-no: 
02.158]). 
 3,6 Nonadienol HO  Not evaluated as flavouring substance  Not in EU-Register. 
 Hex-(3Z)-enoic acid 
OHO  
Not evaluated as flavouring substance  Not in EU-Register. 
 Oct-3-enoic acid 
OH
O
 
Not evaluated as flavouring substance  
 
 
Not in EU-Register (former [FL-no: 
08.105]). 
 Deca-4,8-dienoic acid O
HO
Not evaluated as flavouring substance  Not in EU-Register. 
02.011 Citronellol 
1219 OH  
 
No safety concern a) 
Category A b) 
 
Class I 
A3: Intake below threshold 
 
02.056 Hex-3(cis)-en-1-ol 
315 
OH  Category 1 c) 
No safety concern d) 
Category A b) 
 
Class I 
A3: Intake above threshold, A4: Not 
endogenous, A5: Adequate NOAEL exists 
 
02.074 Hex-4-en-1-ol 
318 
OH
(E)-isomer shown  
Category 2 c) 
No safety concern d) 
Category B b) 
 
Class I 
A3: Intake below threshold 
 
02.078 Ethanol 
41 
OH  Category 1 c) 
No safety concern e) 
 
 
 
No evaluation 
At the forty-sixth JECFA meeting (JECFA, 
1997a), the Committee concluded that 
ethanol posed no safety concern at its 
current level of intake when ethyl esters are 
used as flavouring agents. 
02.093 Non-6-en-1-ol 
324 
OH   
No safety concern d) 
 
 
Class I 
A3: Intake below threshold 
 
02.113 Oct-5(cis)-en-1-ol 
322 
OH  Category 2 c) 
No safety concern d) 
 
Class I 
A3: Intake below threshold 
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Table 2b: Evaluation Status of Hydrolysis Products of Candidate Esters 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
 
02.124 6-Methylhept-5-en-2-ol 
 
OH
 
Category 2 c) 
 
 
FGE.07 
Class I 
A3: Intake below threshold 
 
02.159 Hex-3-en-1-ol 
315 
OH   
 
Category A b) 
 
 
No evaluation 
 
02.170 Lavandulol 
 
OH
 
 
 
FGE.06 
Class I 
A3: Intake below threshold 
 
02.176 3-Methylbut-3-en-1-ol 
 
OH
 
 
 
 
FGE.06 
Class I 
A3: Intake below threshold 
 
02.234 3-Nonen-1-ol 
 
OH   
 
 
FGE.06 
Class I 
A3: Intake below threshold 
 
08.002 Acetic acid 
81 
O
OH  
Category 1 c) 
No safety concern f) 
Category A b) 
 
Class I 
A3: Intake above threshold, A4: 
Endogenous 
 
08.005 Butyric acid 
87 
OH
O
 
Category 1 c) 
No safety concern f) 
Category A b) 
 
Class I 
A3: Intake above threshold, A4: 
Endogenous 
 
08.009 Hexanoic acid 
93 
O
OH  
Category 1 c) 
No safety concern f) 
Category A b) 
 
Class I 
A3: Intake above threshold, A4: 
Endogenous 
 
08.010 Octanoic acid 
99 
OH
O
 
Category 1 c) 
No safety concern f) 
Category A b) 
 
Class I 
A3: Intake above threshold, A4: 
Endogenous 
 
08.011 Decanoic acid 
105 
OH
O
 
Category 1 c) 
No safety concern f) 
Category A b) 
 
Class I 
A3: Intake below threshold 
 
08.012 Dodecanoic acid 
111 
OH
O
 
Category 1 c) 
No safety concern f) 
Category A b) 
 
Class I 
A3: Intake below threshold 
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Table 2b: Evaluation Status of Hydrolysis Products of Candidate Esters 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
08.014 Hexadecanoic acid 
115 
OH
O
 
Category 1 c) 
No safety concern f) 
Deleted b) 
 
Class I 
A3: Intake below threshold 
 
08.028 Heptanoic acid 
96 
OH
O
 
Category 1 c) 
No safety concern f) 
Category A b) 
 
Class I 
A3: Intake below threshold 
 
08.045 2-Ethylbutyric acid 
257 
OH
O
 
Category 1 c) 
No safety concern f) 
Category B b) 
 
Class II 
A3: Intake below threshold 
 
08.075 Dec-4-enoic acid 
1287 
OH
O
(E)-isomer shown  
 
No safety concern a) 
 
 
Class I 
A3: Intake below threshold 
 
08.081 Geranic acid 
1825 
OH
O
 
 
 
 
 
Class I 
A3: Intake below threshold 
 
08.100 4-Methylpent-3-enoic acid 
 
OH
O
 
 
 
 
FGE.06 
Class I 
A3: Intake below threshold 
 
1) Category 1: Considered safe in use   Category 2: Temporarily considered safe in use   Category 3: Insufficient data to provide assurance of safety in use   Category 4): Not acceptable due to evidence of toxicity. 
2) No safety concern at estimated levels of intake. 
3) Category A: Flavouring substance, which may be used in foodstuffs Category B: Flavouring substance which can be used provisionally in foodstuffs. 
4) Threshold of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
5) Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot. 
a) (JECFA, 2004a). 
b) (CoE, 1992). 
c) (SCF, 1995). 
d) (JECFA, 2000a). 
e) (JECFA, 1997a). 
f) (JECFA, 1999b). 
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TABLE 3: SUPPORTING SUBSTANCES SUMMARY 
Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
02.056 Hex-3(cis)-en-1-ol OH  2563 
750c 
928-96-1 
315 
JECFA specification 
(JECFA, 1998b) 
3700 Category 1 a) 
No safety concern b) 
Category A c) 
 
02.074 Hex-4-en-1-ol OH
(E)-isomer shown  
3430 
2295 
6126-50-7 
318 
JECFA specification 
(JECFA, 1998b) 
2.4 Category 2 a) 
No safety concern b) 
Category B c) 
JECFA evaluated 4-
hexen-1-ol (CASrn as in 
Register). (Z)- or (E)-
isomer not specified by 
CASrn in Register. 
02.093 Non-6-en-1-ol OH  3465 
10294 
35854-86-5 
324 
JECFA specification 
(JECFA, 2000d) 
2.2  
No safety concern b) 
 
JECFA evaluated cis-6-
nonen-1-ol (CASrn as in 
Register). CASrn in 
Register refers to (Z)-
isomer. Register name to 
be changed to Non-6Z-
en-1-ol. 
02.094 Oct-3-en-1-ol OH  3467 
10296 
20125-84-2 
321 
JECFA specification 
(JECFA, 1998b) 
4.7 Category 2 a) 
No safety concern b) 
 
JECFA evaluated cis-3-
octen-1-ol (CASrn as in 
Register). CASrn in 
Register refers to the (Z)-
isomer. Register name to 
be changed to Oct-3Z-en-
1-ol. 
02.110 2,6-Dimethylhept-6-en-1-ol 
OH
 
3663 
 
36806-46-9 
348 
JECFA specification 
(JECFA, 2003b) 
ND Category 3 a) 
No safety concern b) 
 
JECFA evaluated 2,6-
dimethyl-6-hepten-1-ol 
(CASrn as in Register). 
(R)- or (S)-enantiomer 
not specified by CASrn in 
Register. 
02.113 Oct-5(cis)-en-1-ol OH  3722 
 
64275-73-6 
322 
JECFA specification 
(JECFA, 2003b) 
0.4 Category 2 a) 
No safety concern b) 
 
 
05.035 Undec-10-enal O  3095 
122 
112-45-8 
330 
JECFA specification 
(JECFA, 2001c) 
0.32  
No safety concern b) 
Category B c) 
 
05.036 Undec-9-enal O
(E)-isomer shown  
3094 
123 
143-14-6 
329 
JECFA specification 
(JECFA, 2003b) 
0.97  
No safety concern b) 
Category A c) 
JECFA evaluated 9-
undecenal (CASrn as in 
Register). (Z)- or (E)-
isomer not specified by 
CASrn in Register. 
05.059 Non-6(cis)-enal O  3580 
661 
2277-19-2 
325 
JECFA specification 
(JECFA, 2003b) 
1.7  
No safety concern b) 
Category B c) 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
05.074 2,6-Dimethylhept-5-enal 
O
 
2389 
2006 
106-72-9 
349 
JECFA specification 
(JECFA, 2003b) 
27 Category 1 a) 
No safety concern b) 
Category B c) 
JECFA evaluated 2,6-
dimethyl-5-heptenal 
(CASrn as in Register). 
(R)- or (S)-enantiomer 
not specified by CASrn in 
Register. 
05.075 Hex-3(cis)-enal O  2561 
2008 
6789-80-6 
316 
JECFA specification 
(JECFA, 2000d) 
4.1  
No safety concern b) 
Category B c) 
 
05.085 Hept-4-enal O
(Z)-isomer shown  
3289 
2124 
6728-31-0 
320 
JECFA specification 
(JECFA, 2000d) 
1.6  
No safety concern b) 
Category B c) 
JECFA evaluated 4-
heptenal (CASrn as in 
Register). CASrn in 
Register refers to the (Z)-
isomer.  
05.096 4-Decenal Ο
(E)-isomer shown  
3264 
2297 
30390-50-2 
326 
JECFA specification 
(JECFA, 2001c) 
0.97  
No safety concern b) 
Category B c) 
JECFA evaluated 4-
decenal (CASrn as in 
Register). (Z)- or (E)-
isomer not specified by 
CASrn in Register. 
05.113 Hex-4-enal O  3496 
10337 
4634-89-3 
319 
JECFA specification 
(JECFA, 2000d) 
0.024  
No safety concern b) 
 
JECFA evaluated cis-4-
hexenal (CASrn as in 
Register). CASrn in 
Register refers to the (Z)-
isomer. Register name to 
be changed to Hex-4Z-
enal. 
05.128 Oct-5(cis)-enal O  3749 
 
41547-22-2 
323 
JECFA specification 
(JECFA, 2003b) 
0.0012  
No safety concern b) 
 
 
08.013 Oleic acid 
OH
O
 
2815 
13 
112-80-1 
333 
JECFA specification 
(JECFA, 2000d) 
830 Category 1 a) 
No safety concern b) 
Deleted c) 
 
08.039 Undec-10-enoic acid 
OH
O
 
3247 
689 
112-38-9 
331 
JECFA specification 
(JECFA, 1998b) 
26 Category 1 a) 
No safety concern b) 
Category A c) 
 
08.041 Octadeca-9,12-dienoic acid 
OH
O
 
3380 
694 
60-33-3 
332 
JECFA specification 
(JECFA, 2003b) 
110 Category 1 a) 
No safety concern b) 
Deleted c) 
Register name to be 
changed to Linoleic acid. 
08.048 Pent-4-enoic acid 
OH
O
 
2843 
2004 
591-80-0 
314 
JECFA specification 
(JECFA, 1998b) 
3.9  
No safety concern b) 
Category B c) 
 
08.050 Hex-3-enoic acid 
OH
O
(E)-isomer shown  
3170 
2256 
4219-24-3 
317 
JECFA specification 
(JECFA, 2000d) 
9.4 Category 1 a) 
No safety concern b) 
Category B c) 
JECFA evaluated 3-
hexenoic acid (CASrn as 
in Register). (Z)- or (E)-
isomer not specified by 
CASrn in Register. 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
08.058 2-Methylpent-3-enoic acid 
OH
O
(E)-isomer shown  
3464 
10147 
37674-63-8 
347 
JECFA specification 
(JECFA, 2001c) 
1.2 Category 1 a) 
No safety concern b) 
 
JECFA evaluated 2-
methyl-3-pentenoic-acid 
(CASrn as in Register). 
(Z)- or (E)-isomer not 
specified by CASrn in 
Register. 
08.059 2-Methylpent-4-enoic acid 
OH
O
 
3511 
10148 
1575-74-2 
355 
JECFA specification 
(JECFA, 1998b) 
ND Category N a) 
No safety concern b) 
 
JECFA evaluated 2-
methyl-4-pentenoic-acid 
(CASrn as in Register). 
(R)- or (S)-enantiomer 
not specified by CASrn in 
Register. 
08.065 Dec-9-enoic acid 
OH
O
 
3660 
10090 
14436-32-9 
328 
JECFA specification 
(JECFA, 2001c) 
0.097 Category 1 a) 
No safety concern b) 
 
 
08.068 Dec-(5- and 6)-enoic acid 
OH
O
OH
O
(E)-isomers shown
3742 
 
72881-27-7 
327 
JECFA specification 
(JECFA, 2000d) 
3.4 Category N a) 
No safety concern b) 
 
JECFA evaluated 5 & 6-
decenoic acid (mixture) 
(CASrn as in Register). 
CASrn in Register refers 
to incompletely defined 
substance. 
09.011 Geranyl acetate 
O
O
 
2509 
201 
105-87-3 
58 
JECFA specification 
(JECFA, 2001c) 
470  
No safety concern d) 
Category A c) 
GrADI: 0-0.5 (JECFA, 
1980a). 
09.012 Citronellyl acetate 
O
O
 
2311 
202 
150-84-5 
57 
JECFA specification 
(JECFA, 2003b). (R) or 
(S) enatiomer not 
specified by CASrn in 
Register 
190  
No safety concern d) 
Category A c) 
GrADI: 0-0.5 (JECFA, 
1980a). R- or S-
enantiomer not specified 
by CASrn in Register. 
09.033 Rhodinyl acetate 
O
O
 
2981 
223 
141-11-7 
60 
JECFA specification 
(JECFA, 2003b) 
0.97  
No safety concern d) 
Deleted c) 
CASrn in Register refers 
to 3,7-dimethyl-7-octen-
1-ol-1-acetate; (R)- or 
(S)-enantiomer not 
specified by CASrn in 
Register. Register name 
corresponds to CASrn 
9448-73-9; which is the 
(S)-enantiomer. 
09.048 Geranyl butyrate 
O
O
 
2512 
274 
106-29-6 
66 
JECFA specification 
(JECFA, 2003b) 
52  
No safety concern d) 
Category A c) 
 
09.049 Citronellyl butyrate 
OO
2312 
275 
141-16-2 
65 
JECFA specification 
(JECFA, 2003b) 
27  
No safety concern d) 
Category A c) 
R- or S-enantiomer not 
specified by CASrn in 
Register. 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
09.067 Geranyl hexanoate O
O  
2515 
317 
10032-02-7 
70 
JECFA specification 
(JECFA, 2001c) 
0.061  
No safety concern d) 
Category A c) 
 
09.076 Geranyl formate 
OO  
2514 
343 
105-86-2 
54 
JECFA specification 
(JECFA, 2003b) 
280  
No safety concern d) 
Category A c) 
 
09.078 Citronellyl formate 
O O  
2314 
345 
105-85-1 
53 
JECFA specification 
(JECFA, 2005b) 
87  
No safety concern d) 
Category A c) 
GrADI: 0-0.5 (JECFA, 
1980a). R- or S-
enantiomer not specified 
by CASrn in Register. 
09.079 Rhodinyl formate 
O
O
 
2984 
346 
141-09-3 
56 
JECFA specification 
(JECFA, 2003b) 
0.061  
No safety concern d) 
Deleted c) 
R- or S-enantiomer not 
specified by CASrn in 
Register. 
09.128 Geranyl propionate 
O
O
 
2517 
409 
105-90-8 
62 
JECFA specification 
(JECFA, 2003b) 
69  
No safety concern d) 
Category A c) 
 
09.129 Citronellyl propionate O
O  
2316 
410 
141-14-0 
61 
JECFA specification 
(JECFA, 2003b) 
35  
No safety concern d) 
Category A c) 
R- or S-enantiomer not 
specified by CASrn in 
Register. 
09.141 Rhodinyl propionate 
O
O
2986 
422 
105-89-5 
64 
JECFA specification 
(JECFA, 2001c) 
ND  
No safety concern d) 
Deleted c) 
R- or S-enantiomer not 
specified by CASrn in 
Register. 
09.151 Citronellyl valerate 
O
O
 
2317 
469 
7540-53-6 
69 
JECFA specification 
(JECFA, 2000d) 
0.61  
No safety concern d) 
Category A c) 
R- or S-enantiomer not 
specified by CASrn in 
Register. 
09.167 Neryl butyrate 
O
O
2774 
505 
999-40-6 
67 
JECFA specification 
(JECFA, 1997b) 
0.35  
No safety concern d) 
Category B c) 
 
09.169 Neryl propionate 
O
O
2777 
509 
105-91-9 
63 
JECFA specification 
(JECFA, 1997b) 
3.7  
No safety concern d) 
Category B c) 
 
09.191 Ethyl hex-3-enoate 
O
O
(Z)-isomer shown  
3342 
 
2396-83-0 
335 
JECFA specification 
(JECFA, 1998b) 
3.2  
No safety concern b) 
 
JECFA evaluated ethyl-3-
hexenoate (CASrn as in 
Register). (Z)- or (E)-
isomer not specified by 
CASrn in Register. 
09.192 Ethyl oleate 
O
O
 
2450 
633 
111-62-6 
345 
JECFA specification 
(JECFA, 1998b) 
60  
No safety concern b) 
Category A c) 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
09.212 Neryl formate 
O
O
2776 
2060 
2142-94-1 
55 
JECFA specification 
(JECFA, 2005b) 
0.0061  
No safety concern d) 
Category B c) 
 
09.213 Neryl acetate 
O
O
2773 
2061 
141-12-8 
59 
JECFA specification 
(JECFA, 1997b) 
150  
No safety concern d) 
Category B c) 
 
09.236 Methyl undec-9-enoate 
O
O
(E)-isomer shown  
2750 
2101 
5760-50-9 
342 
JECFA specification 
(JECFA, 2000d) 
34  
No safety concern b) 
Deleted c) 
JECFA evaluated methyl 
9-undecanoate (CASrn as 
in Register). (Z)- or (E)-
isomer not specified by 
CASrn in Register. 
09.237 Ethyl undec-10-enoate 
O
O
 
2461 
10634 
692-86-4 
343 
JECFA specification 
(JECFA, 1998b) 
1.5  
No safety concern b) 
Deleted c) 
 
09.238 Butyl undec-10-enoate 
O
O
 
2216 
2103 
109-42-2 
344 
JECFA specification 
(JECFA, 2001c) 
0.037  
No safety concern b) 
Category B c) 
 
09.265 Ethyl oct-4-enoate 
O
O
 
3344 
10619 
34495-71-1 
338 
JECFA specification 
(JECFA, 2003b) 
1.2  
No safety concern b) 
 
JECFA evaluated ethyl 
cis-4-octenoate (CASrn 
as in Register). CASrn in 
Register refers to (Z)-
isomer. Register name to 
be changed to Ethyl oct-
4Z-enoate. 
09.267 Methyl hex-3-enoate 
O
O
(E)-isomer shown
3364 
10801 
2396-78-3 
334 
JECFA specification 
(JECFA, 2001c) 
0.56  
No safety concern b) 
 
Z- or E-isomer not 
specified by name and 
CASrn in Register. 
09.268 Methyl oct-4(cis)-enoate 
O
O
 
3367 
10834 
21063-71-8 
337 
JECFA specification 
(JECFA, 2003b) 
0.37  
No safety concern b) 
 
 
09.284 Ethyl dec-4-enoate 
O
O
 
3642 
10578 
76649-16-6 
341 
JECFA specification 
(JECFA, 2000d) 
1.8  
No safety concern b) 
 
JECFA evaluated ethyl 
trans-4-decenoate (CASrn 
as in Register). CASrn 
refers to (E)-isomer. 
Register name to be 
changed to E-Ethyl dec-4-
enoate. 
09.290 Ethyl octa-4,7-dienoate 
O
O
 
3682 
 
69925-33-3 
339 
JECFA specification 
(JECFA, 2000d) 
1.8  
No safety concern b) 
 
JECFA evaluated ethyl 
cis-4,7-octadienoate 
(CASrn as in Register). 
CASrn in Register refers 
to the (Z)-isomer. 
Register name to be 
changed to Ethyl octa-
4Z,7-dienoate. 
Flavouring Group Evaluation 06, Revision 3 
 
 
39 EFSA Journal 2011; 9(11):2397 
Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
09.291 Hex-3-enyl hex-3-enoate 
O
O
 
3689 
 
61444-38-0 
336 
JECFA specification 
(JECFA, 1998b) 
3.2  
No safety concern b) 
 
JECFA evaluated cis-3-
hexenyl cis-3-hexenoate 
(CASrn as in Register). 
CASrn in Register refers 
to the (Z)/(Z)-isomer. 
Register name to be 
changed to Hex-3Z-enyl 
hex-3Z-enoate. 
09.298 Methyl non-3-enoate 
O
O
(E)-isomer shown  
3710 
 
13481-87-3 
340 
JECFA specification 
(JECFA, 2000d) 
1.6  
No safety concern b) 
 
JECFA evaluated methyl 
3-nonenoate (CASrn as in 
Register). (Z)- or (E)-
isomer not specified by 
CASrn in Register. 
09.421 Citronellyl isobutyrate 
O
O 2313 
296 
97-89-2 
71 
JECFA specification 
(JECFA, 2003b) 
11  
No safety concern d) 
Category A c) 
R- or S-enantiomer not 
specified by CASrn in 
Register. 
09.424 Neryl isobutyrate 
O
O
2775 
299 
2345-24-6 
73 
JECFA specification 
(JECFA, 2003b) 
1.7  
No safety concern d) 
Category B c) 
 
09.431 Geranyl isobutyrate 
O
O
2513 
306 
2345-26-8 
72 
JECFA specification 
(JECFA, 2001c) 
110  
No safety concern d) 
Category B c) 
 
09.453 Geranyl isovalerate O
O  
2518 
448 
109-20-6 
75 
JECFA specification 
(JECFA, 2000d) 
41  
No safety concern d) 
Category B c) 
 
09.465 Rhodinyl isovalerate 
O
O
2987 
460 
7778-96-3 
77 
JECFA specification 
(JECFA, 2001c) 
0.012  
No safety concern d) 
Deleted c) 
CASrn in Register refers 
to 3S-enantiomer. 
09.471 Neryl isovalerate 
O
O
2778 
508 
3915-83-1 
76 
JECFA specification 
(JECFA, 1997b) 
0.024  
No safety concern d) 
Category B c) 
 
09.515 Geranyl 2-ethylbutyrate 
O
O
3339 
11667 
73019-14-4 
78 
JECFA specification 
(JECFA, 2001c) 
0.49  
No safety concern d) 
 
 
09.517 Methyl citronellate O
O
3361 
10781 
2270-60-2 
354 
JECFA specification 
(JECFA, 2000d) 
0.13  
No safety concern b) 
 
R- or S-enantiomer not 
specified by CASrn in 
Register. 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
09.524 Ethyl 2-methylpent-3-enoate 
O
O
(Z)-isomer shown  
3456 
10612 
1617-23-8 
350 
JECFA specification 
(JECFA, 2001c) 
4.9  
No safety concern b) 
 
JECFA evaluated ethyl 2-
methyl-3-pentenoate 
(CASrn as in Register). 
(Z)- or (E)-isomer nor (R) 
or (S) enantiomer not 
specified by Register 
CASrn. 
09.527 Ethyl 2-methylpent-4-enoate 
O
O 3489 
10613 
53399-81-8 
351 
JECFA specification 
(JECFA, 1998b) 
0.024  
No safety concern b) 
 
(R) or (S) enantiomer not 
specified by Register 
CASrn. 
09.540 Ethyl 2-methylpenta-3,4-
dienoate 
O
O 3678 
 
60523-21-9 
353 
JECFA specification 
(JECFA, 2000d) 
0.012  
No safety concern e) 
 
(R) or (S) enantiomer not 
specified by Register 
CASrn. 
09.546 Hexyl-2-methylpent-(3 and 4)-
enoate 
O
O
O
O
(Z)-isomer shown
 
3693 
 
58625-95-9 
352 
JECFA specification 
(JECFA, 2001c) 
0.024  
No safety concern b) 
 
JECFA evaluated hexyl 
2-methyl-3&4-pentenoate 
(mixture) (CASrn as in 
Register). Register CASrn 
refers to the (E)-isomer. 
(R) or (S) enantiomer not 
specified by Register 
CASrn. 
09.571 Hex-3-enyl valerate O
O
(Z)-isomer shown  
3936 
10686 
35852-46-1 
1278 
JECFA specification 
(JECFA, 2003b) 
6.1  
No safety concern f) 
 
JECFA evaluated cis-3-
hexenyl valerate (CASrn 
as in Register). Register 
CASrn refers to the (Z)-
isomer.  
09.646 Methyl linolenate 
O
O
 
3411 
714 
301-00-8 
346 
JECFA specification 
(JECFA, 2003b) 
ND  
No safety concern b) 
Category A c) 
JECFA evaluated a 
mixture of methyl 
linoleate and methyl 
linolenate (CASrn as in 
Register). Register CASrn 
refers to the (Z)/(Z)/(Z)-
isomer (i.e. methyl 
linolenate). 
09.655 3-Methylbut-3-enyl acetate 
O
O
 
3991 
 
5205-07-2 
1269 
JECFA specification 
(JECFA, 2003b) 
7.3  
No safety concern f) 
 
 
09.927 Rhodinyl butyrate 
O
O
2982 
 
141-15-1 
68 
JECFA specification 
(JECFA, 2005b) 
ND  
No safety concern d) 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
09.940 Rhodinyl isobutyrate 
O
O
2983 
 
138-23-8 
74 
JECFA specification 
(JECFA, 2001c) 
0.012  
No safety concern d) 
 
JECFA CASrn 1338-23-8 
not valid. 
1) EU MSDI: Amount added to food as flavouring substance in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Category 1: Considered safe in use, Category 2: Temporarily considered safe in use, Category 3: Insufficient data to provide assurance of safety in use, Category 4: Not acceptable due to evidence of toxicity. 
3) No safety concern at estimated levels of intake. 
4) Category A: Flavouring substance, which may be used in foodstuffs, Category B: Flavouring substance which can be used provisionally in foodstuffs. 
a) (SCF, 1995). 
b) (JECFA, 2000a). 
c) (CoE, 1992). 
d) (JECFA, 1999b). 
e) (JECFA, 2007c). 
f) (JECFA, 2004a). 
 
Flav
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ANNEX I: PROCEDURE FOR THE SAFETY EVALUATION 
The approach for a safety evaluation of chemically defined flavouring substances as referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), named the "Procedure", is shown in schematic 
form in Figure I.1. The Procedure is based on the Opinion of the Scientific Committee on Food expressed on 
2 December 1999 (SCF, 1999a), which is derived from the evaluation Procedure developed by the Joint 
FAO/WHO Expert Committee on Food Additives at its 44th, 46th and 49th meetings (JECFA, 1995; JECFA, 
1996a; JECFA, 1997a; JECFA, 1999b). 
The Procedure is a stepwise approach that integrates information on intake from current uses, structure-
activity relationships, metabolism and, when needed, toxicity. One of the key elements in the Procedure is 
the subdivision of flavourings into three structural classes (I, II, III) for which thresholds of concern (human 
exposure thresholds) have been specified. Exposures below these thresholds are not considered to present a 
safety concern. 
Class I contains flavourings that have simple chemical structures and efficient modes of metabolism, which 
would suggest a low order of oral toxicity. Class II contains flavourings that have structural features that are 
less innocuous, but are not suggestive of toxicity. Class III comprises flavourings that have structural 
features that permit no strong initial presumption of safety, or may even suggest significant toxicity (Cramer 
et al., 1978). The thresholds of concern for these structural classes of 1800, 540 or 90 microgram/person/day, 
respectively, are derived from a large database containing data on subchronic and chronic animal studies 
(JECFA, 1996a). 
In Step 1 of the Procedure, the flavourings are assigned to one of the structural classes. The further steps 
address the following questions: 
• can the flavourings be predicted to be metabolised to innocuous products8 (Step 2)?  
• do their exposures exceed the threshold of concern for the structural class (Step A3 and B3)? 
• are the flavourings or their metabolites endogenous9 (Step A4)?  
• does a NOAEL exist on the flavourings or on structurally related substances (Step A5 and B4)? 
In addition to the data provided for the flavouring substances to be evaluated (candidate substances), 
toxicological background information available for compounds structurally related to the candidate 
substances is considered (supporting substances), in order to assure that these data are consistent with the 
results obtained after application of the Procedure.  
The Procedure is not to be applied to flavourings with existing unresolved problems of toxicity. Therefore, 
the right is reserved to use alternative approaches if data on specific flavourings warranted such actions. 
 
                                                     
 
8 “Innocuous metabolic products”: Products that are known or readily predicted to be harmless to humans at the 
estimated intakes of the flavouring agent” (JECFA, 1997a). 
 
9 “Endogenous substances”: Intermediary metabolites normally present in human tissues and fluids, whether free or 
conjugated; hormones and other substances with biochemical or physiological regulatory functions are not included 
(JECFA, 1997a). 
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Decision tree structural class 
Can the substance be predicted to be metabolised to innocuous products?
Procedure for Safety Evaluation of Chemically Defined Flavouring Substances 
Do the conditions of use result in an intake greater than the 
threshold of concern for the structural class?
Do the conditions of use result in an intake greater than the  
threshold of concern for the structural class? 
Data must be available on the  
substance or closely related  
substances to perform a safety 
evaluation
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is  high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
  Substance would not be    
expected to be of safety concern
Is the substance or are its metabolites endogenous?
Additional data required 
Step 1. 
Step 2. 
Step A3. 
Step A4. 
Step A5. 
Step B3. 
Step B4.
 Yes No
 Yes 
 No 
No
No
Yes
No
Yes
Yes
Yes
 No
Figure I.1 Procedure for Safety Evaluation of Chemically Defined Flavouring Substances
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ANNEX II: USE LEVELS / MTAMDI 
II.1 Normal and Maximum Use Levels 
For each of the 18 Food categories (Table II.1.1) in which the candidate substances are used, Flavour 
Industry reports a “normal use level” and a “maximum use level” (EC, 2000a). According to the Industry the 
”normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th 
percentile of reported usages (EFFA, 2002i). The normal and maximum use levels in different food 
categories have been extrapolated from figures derived from 12 model flavouring substances (EFFA, 2004e). 
Table II.1.1 Food categories according to Commission Regulation (EC) No 1565/2000 (EC, 2000a) 
Food category Description 
01.0 Dairy products, excluding products of category 02.0 
02.0 Fats and oils, and fat emulsions (type water-in-oil) 
03.0 Edible ices, including sherbet and sorbet 
04.1 Processed fruit 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts & seeds 
05.0 Confectionery 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, excluding bakery 
07.0 Bakery wares 
08.0 Meat and meat products, including poultry and game 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  
10.0 Eggs and egg products 
11.0 Sweeteners, including honey 
12.0 Salts, spices, soups, sauces, salads, protein products, etc. 
13.0 Foodstuffs intended for particular nutritional uses 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts 
15.0 Ready-to-eat savouries 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be placed in categories 01.0 - 15.0 
 
The “normal and maximum use levels” are provided by Industry (EFFA, 2001e; EFFA, 2002a; EFFA, 
2004v; EFFA, 2006d; EFFA, 2007a; Flavour Industry, 2004a; Flavour Industry, 2009w) for 49 of the 
candidate substances in the present flavouring group (Table II.1.2). 
Table II.1.2.Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.06Rev3 (EFFA, 
2001e; EFFA, 2002a; EFFA, 2004v; EFFA, 2006d; EFFA, 2007a; Flavour Industry, 2004a; Flavour Industry, 
2009w) 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
02.125 - 
- 
- 
- 
4 
10 
- 
- 
- 
- 
4 
10 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
4 
10 
4 
10 
- 
- 
- 
- 
02.138 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.152 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.170 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.175 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.176 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.195 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.201 7 5 10 7 - 10 5 10 2 2 - - 5 10 5 10 20 5 
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Table II.1.2.Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.06Rev3 (EFFA, 
2001e; EFFA, 2002a; EFFA, 2004v; EFFA, 2006d; EFFA, 2007a; Flavour Industry, 2004a; Flavour Industry, 
2009w) 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
35 25 50 35 - 50 25 50 10 10 - - 25 50 25 50 100 25 
02.222 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.234 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
- 
- 
5 
25 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
05.061 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
05.082 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
05.143 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
- 
- 
- 
- 
2 
10 
4 
20 
3 
15 
2 
10 
05.174 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
05.203 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
05.217 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
05.218 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
05.220 0,05 
0,16 
- 
- 
0,08 
0,16 
0,04 
0,08 
- 
- 
0,1 
8 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
0,05 
0,1 
0,08 
0,16 
0,1 
0,2 
- 
- 
05.226 - 
- 
0,08 
0,1 
0,1 
0,16 
0,1 
0,16 
0,1 
0,16 
0,18 
0,26 
0,05 
0,08 
0,05 
0,1 
0,1 
0,16 
- 
- 
- 
- 
- 
- 
0,1 
0,16 
- 
- 
0,1 
0,16 
0,08 
0,1 
- 
- 
- 
- 
08.074 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
3 
15 
10 
50 
15 
75 
5 
25 
08.100 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
3 
15 
10 
50 
15 
75 
5 
25 
08.102 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
3 
15 
10 
50 
15 
75 
5 
25 
09.341 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.368 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.377 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.567 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.569 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.572 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.575 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.612 7 
35 
2 
10 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.638 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.640 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.643 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.672 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.673 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.831 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.838 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.855 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.871 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.872 7 5 10 7 - 10 5 10 2 2 - - 5 10 5 10 20 5 
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Table II.1.2.Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.06Rev3 (EFFA, 
2001e; EFFA, 2002a; EFFA, 2004v; EFFA, 2006d; EFFA, 2007a; Flavour Industry, 2004a; Flavour Industry, 
2009w) 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
35 25 50 35 - 50 25 50 10 10 - - 25 50 25 50 100 25 
09.884 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.885 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.897 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.898 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.928 7 
35 
5 
25 
10 
50 
7 
35 
7 
35 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.937 0,02 
0,4 
0,02 
0,4 
0,2 
4 
0,02 
0,4 
0,02 
0,4 
2 
40 
0,4 
8 
0,2 
4 
0,02 
0,4 
0,02 
0,4 
- 
- 
- 
- 
0,02 
0,4 
- 
- 
2 
40 
2 
40 
0,02 
0,4 
0,02 
0,4 
09.938 1 
5 
1 
5 
10 
50 
1 
5 
1 
5 
100 
500 
20 
100 
10 
50 
1 
5 
1 
5 
- 
- 
- 
- 
1 
5 
- 
- 
100 
500 
100 
500 
1 
5 
1 
5 
09.939 0,02 
0,4 
0,2 
0,4 
0,2 
4 
0,02 
0,4 
0,02 
0,4 
2 
40 
0,4 
8 
0,2 
4 
0,02 
0,4 
0,02 
0,4 
- 
- 
- 
- 
0,02 
0,4 
- 
- 
2 
40 
2 
40 
0,02 
0,4 
0,02 
0,4 
09.950 16 
20 
9 
11 
16 
20 
16 
20 
16 
20 
16 
20 
8 
10 
8 
10 
- 
- 
- 
- 
- 
- 
8 
10 
8 
10 
- 
- 
14 
18 
16 
20 
16 
20 
- 
- 
II.2 mTAMDI Calculations 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values is 
based on the approach used by SCF up to 1995 (SCF, 1995). The assumption is that a person may consume 
the amount of flavourable foods and beverages listed in Table II.2.1. These consumption estimates are then 
multiplied by the reported use levels in the different food categories and summed up.  
Table II.2.1 Estimated amount of flavourable foods, beverages, and exceptions assumed to be consumed per 
person per day (SCF, 1995) 
Class of product category Intake estimate (g/day) 
Beverages (non-alcoholic) 324.0 
Foods 133.4 
Exception a: Candy, confectionery 27.0 
Exception b: Condiments, seasonings 20.0 
Exception c: Alcoholic beverages 20.0 
Exception d: Soups, savouries 20.0 
Exception e: Others, e.g. chewing gum e.g. 2.0 (chewing gum) 
 
The mTAMDI calculations are based on the normal use levels reported by Industry. The seven food 
categories used in the SCF TAMDI approach (SCF, 1995) correspond to the 18 food categories as outlined in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a) and reported by the Flavour Industry in the 
following way (see Table II.2.2): 
• Beverages (SCF, 1995) correspond to food category 14.1 (EC, 2000a) 
• Foods (SCF, 1995) correspond to the food categories 1, 2, 3, 4.1, 4.2, 6, 7, 8, 9, 10, 13, and/or 16 
(EC, 2000a) 
• Exception a (SCF, 1995) corresponds to food category 5 and 11 (EC, 2000a) 
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• Exception b (SCF, 1995) corresponds to food category 15 (EC, 2000a) 
• Exception c (SCF, 1995) corresponds to food category 14.2 (EC, 2000a) 
• Exception d (SCF, 1995) corresponds to food category 12 (EC, 2000a) 
• Exception e (SCF, 1995) corresponds to others, e.g. chewing gum. 
Table II.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 
2000a) into the seven SCF food categories used for TAMDI calculation (SCF, 1995) 
 Food categories according to Commission Regulation 1565/2000 Distribution of the seven SCF food categories 
Key Food category Food Beverages Exceptions 
01.0 Dairy products, excluding products of category 02.0 Food   
02.0 Fats and oils, and fat emulsions (type water-in-oil) Food   
03.0 Edible ices, including sherbet and sorbet Food   
04.1 Processed fruit Food   
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), 
and nuts & seeds 
Food   
05.0 Confectionery   Exception a 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & 
legumes, excluding bakery 
Food   
07.0 Bakery wares Food   
08.0 Meat and meat products, including poultry and game Food   
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  Food   
10.0 Eggs and egg products Food   
11.0 Sweeteners, including honey   Exception a 
12.0 Salts, spices, soups, sauces, salads, protein products, etc.    Exception d 
13.0 Foodstuffs intended for particular nutritional uses Food   
14.1 Non-alcoholic ("soft") beverages, excl. dairy products  Beverages  
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts   Exception c 
15.0 Ready-to-eat savouries   Exception b 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be 
placed in categories 01.0 - 15.0 
Food   
 
The mTAMDI values (see Table II.2.3) are presented for each of the 49 flavouring substances in the present 
flavouring group, for which Industry has provided use and use levels (EFFA, 2001e; EFFA, 2002a; EFFA, 
2004v; EFFA, 2006d; EFFA, 2007a; Flavour Industry, 2004a; Flavour Industry, 2009w). The mTAMDI 
values are only given for the highest reported normal use levels (see Table II.2.3). 
TableII.2.3 Estimated intakes based on the mTAMDI approach 
FL-no EU Register name mTAMDI 
(μg/person/day) 
Structural class Threshold of concern 
(µg/person/day) 
02.125 Undec-10-en-1-ol 2000 Class I 1800 
02.138 Dec-9-en-1-ol 3900 Class I 1800 
02.152 Hept-3-en-1-ol 3900 Class I 1800 
02.170 Lavandulol 3900 Class I 1800 
02.175 2-Methylbut-3-en-1-ol 3900 Class I 1800 
02.176 3-Methylbut-3-en-1-ol 3900 Class I 1800 
02.195 Octa-3,5-dien-1-ol 3900 Class I 1800 
02.201 Pent-4-en-1-ol 3900 Class I 1800 
02.222 3-Pentenol-1 3900 Class I 1800 
02.234 3-Nonen-1-ol 3900 Class I 1800 
05.061 Oct-6-enal 1600 Class I 1800 
05.082 Dodeca-3,6-dienal 1600 Class I 1800 
05.174 Pent-4-enal 1600 Class I 1800 
05.203 9-Octadecenal 1600 Class I 1800 
05.217 5-Decenal 1600 Class I 1800 
05.218 16-Octadecenal 1600 Class I 1800 
05.220 4Z-Dodecenal 36 Class I 1800 
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05.226 E-4-Undecenal 54 Class I 1800 
08.074 Dec-3-enoic acid 3200 Class I 1800 
08.100 4-Methylpent-3-enoic acid 3200 Class I 1800 
08.102 Non-3-enoic acid 3200 Class I 1800 
09.341 Citronellyl hexanoate 3900 Class I 1800 
09.368 Ethyl 4-methylpent-3-enoate 3900 Class I 1800 
09.377 Ethyl oct-3-enoate 3900 Class I 1800 
09.567 Hex-3-enyl decanoate 3900 Class I 1800 
09.569 Hex-3-enyl octanoate 3900 Class I 1800 
09.572 Hex-4-enyl acetate 3900 Class I 1800 
09.575 3-Hexenyl heptanoate 3900 Class I 1800 
09.612 Lavandulyl acetate 3900 Class I 1800 
09.638 Methyl dec-4-enoate 3900 Class I 1800 
09.640 Methyl deca-4,8-dienoate 3900 Class I 1800 
09.643 Methyl geranate 3900 Class I 1800 
09.672 Non-3-enyl acetate 3900 Class I 1800 
09.673 Non-6-enyl acetate 3900 Class I 1800 
09.674 Nona-3,6-dienyl acetate  Class I 1800 
09.831 Ethyl 3,7-dimethyl-2,6-octadienoate 3900 Class I 1800 
09.838 3-Hexenyl methyl carbonate 3900 Class I 1800 
09.855 trans-3-Hexenyl hexanoate 3900 Class I 1800 
09.871 Citronellyl decanoate 3900 Class I 1800 
09.872 Citronellyl dodecanoate 3900 Class I 1800 
09.885 Hex-3-enyl hexadecanoate 3900 Class I 1800 
09.897 3-Methylbut-3-en-1-yl butyrate 3900 Class I 1800 
09.898 3-Methylbut-3-en-1-yl hexanoate 3900 Class I 1800 
09.928 trans-3-Hexenyl acetate 3900 Class I 1800 
09.937 Methyl (3Z)-hexenoate 800 Class I 1800 
09.938 6-Methyl-5-hepten-2-yl acetate 40000 Class I 1800 
09.939 Ethyl (3Z)-hexenoate 800 Class I 1800 
09.950 Z-5-Octenyl acetate 7900 Class I 1800 
05.143 2,5-Dimethyl-2-vinylhex-4-enal 1600 Class II 540 
09.884 Hex-3-enyl-2-ethylbutyrate 3900 Class II 540 
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ANNEX III: METABOLISM 
III.1. Introduction 
The present FGE consists of 50 straight- and branched-chain unsaturated primary alcohols, aldehydes, 
carboxylic acids and esters.  
Groups with 70 related supporting substances has been evaluated by the JECFA (JECFA, 1998a; JECFA, 
1999a; JECFA, 2004b). 
III.2. Absorption, Distribution and Elimination 
Specific information regarding absorption, distribution, metabolism and excretion is not available for any of 
the candidate substances. 
However, in general, short chain (< C8) linear and branched-chain saturated/unsaturated aliphatic esters, 
alcohols, aldehydes and carboxylic acids are absorbed from the gastrointestinal tract (JECFA, 2000a; 
Dawson et al., 1964b; Gaillard and Derache, 1965). Long-chain carboxylic acids, such as linoleic acid and 
oleic acid, are readily absorbed from micelles in the jejunum, re-esterified with glycerol in chylomicrons and 
transported via the lymphatic system (Borgström, 1974). Radiolabeled linoleic and oleic acids have been 
administered by different routes to a variety of mammals and humans, demonstrating that fatty acid uptake 
occurs in all tissues, including the brain, by passive/facilitated diffusion and/or active transport 
(Dhopeshwarkar and Mead, 1973; Harris et al., 1980; Abumrad et al., 1984; Schulthess et al., 2000). Large 
lipid soluble organic molecules are absorbed by passive diffusion across hydrophobic domains in cell 
membranes (Klaassen, 1996). 
A more detailed discussion follows on metabolism of linear saturated/unsaturated primary alcohols, 
aldehydes and carboxylic acids, and branched-chain unsaturated primary alcohols, aldehydes and carboxylic 
acids.  
A relevant discussion of the general aspects of metabolism for these types of substances may be found in 
FAO/WHO JECFA 42/51 (JECFA, 2000a). 
III.3. Metabolism 
III.3.1. Hydrolysis of Esters in vitro 
Aliphatic esters are hydrolysed to the component alcohols and carboxylic acids as shown in Figure III.1. The 
carboxylesterase or esterase classes of enzymes, the most important of which are the beta-esterases, catalyse 
ester hydrolysis (Heymann, 1980). In mammals, these enzymes occur throughout the body in most tissues 
(Heymann, 1980), but predominate in the hepatocytes (Heymann, 1980). The substrate specificity of beta-
carboxylesterase isoenzymes has been correlated with the structure of the alcohol and carboxylic acid 
components (i.e. R and R’, see Figure III.1) (Heymann, 1980). 
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Figure III.1 Ester hydrolysis 
 
In vitro hydrolysis studies of various esters have been performed with specific carboxylesterase isoenzymes 
isolated from pig and rat livers (Junge and Heymann, 1979; Arndt and Krisch, 1973). Different isoenzymes 
showed large differences in hydrolysis rates, pending on the chain length of the carboxyl and the alcohol 
moiety. The authors concluded that it appears reasonable to assume a coorperative and complementary 
function of the different carboxylesterase enzymes in the hydrolysis of the various esters (Junge and 
Heymann, 1979). 
In vitro hydrolysis data have been reported for structurally related esters of saturated linear and branched-
chain carboxylic acids. Butyl acetate, ethyl butyrate, ethyl heptanoate, ethyl nonanoate and ethyl laurate were 
10 to 37 % hydrolysed in artificial gastric juice (pH 1.2 at 37 °C) in two hours, and 72 to 100 % hydrolysed 
in artificial pancreatic juice (pH 7.5 at 37 °C) in one to two hours (Gangolli and Shilling, 1968). The half-
lives of ethyl butyrate, ethyl heptanoate and ethyl laurate are in the range from 490 to 770 minutes in 
artificial gastric juice and from approximately 5.7 to 9.8 minutes in artificial pancreatic juice (Longland et 
al., 1977). The half-lives of butyl acetate, isoamyl butyrate, ethyl hexanoate and ethyl heptanoate were 
0.0491 to 0.492 seconds in rat liver tissue preparations and 0.0108 to 0.550 seconds in rat small intestinal 
mucosa (Longland et al., 1977). A concentration of 15 microlitre citronellyl acetate/l was reported to be 
completely hydrolysed within two hours by simulated intestinal fluid containing pancreatin (Grundschober, 
1977). A concentration of < 18 microlitre citronellyl phenylacetate/l was reported to be 60 % hydrolysed 
within two hours (Grundschober, 1977). 
Generally hydrolysis appears to be faster in homogenates from rat liver and intestinal mucosa than in 
artificial gastric and pancreatic juices (Longland et al., 1977). 
An in vitro hydrolysis study on carbonate esters of alpha-, beta-naphtol and p-nitrophenol showed that 
carbonate esters are also hydrolysed by liver carboxyl esterase from human, rat and mouse (Huang et al., 
1993). 
 
In vitro hydrolysis data from studies with esters related to the candidate substances, indicate that the esters 
included in this evaluation can be hydrolysed in the gut to yield the corresponding alcohols and carboxylic 
acids of the esters prior to absorption or in the liver following absorption (Grundschober, 1977; Longland et 
al., 1977; Gangolli and Shilling, 1968; Leegwater and Straten, 1974a). 
III.3.2. Metabolism of Linear Saturated/Unsaturated Primary Alcohols, Aldehydes, and Carboxylic acids 
The alcohols formed via ester or acetal hydrolysis are subsequently oxidized to the corresponding aldehydes 
(formed by the oxidation of alcohols to their corresponding aldehydes), which are efficiently oxidized to the 
corresponding saturated/unsaturated carboxylic acids by high capacity enzyme pathways. Isoenzyme 
mixtures of NAD+/NADH-dependent alcohol dehydrogenase (ADH) obtained from human liver microsomes 
have been reported to catalyse oxidation of linear primary aliphatic saturated/unsaturated alcohols 
(Pietruszko et al., 1973). A comparison of the alcohol structure with enzyme binding affinity of ADH 
indicates that increased binding (lower Km) occurs with increasing chain length (i.e. C1 to C6) of the 
substrate and the presence of unsaturation. However, maximum reaction rates of oxidation are essentially 
constant regardless of the alcohol structure suggesting that alcohol-enzyme binding is not the rate limiting 
step for oxidation; rather, the activity of this enzyme appears to be dependent upon the lipophilic character of 
the alcohol substrate (Klesov et al., 1977). 
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Similarly, aldehyde dehydrogenase (ALDH) present predominantly in hepatic cytosol exhibits broad 
specificity for oxidation of aldehydes (Feldman and Weiner, 1972; Eckfeldt and Yonetani, 1982). ALDH is 
more active for higher molecular weight aldehydes (Nakayasu et al., 1978). Xanthine oxidase and aldehyde 
oxidase also catalyse oxidation of a wide range of aldehydes to the corresponding unsaturated carboxylic 
acids (Beedham, 1988). 
At elevated levels of exposure and prior to oxidation to the corresponding carboxylic acid, the aldehyde may 
conjugate with sulphydryl groups such as glutathione to yield thiohemiacetals. Oxidation of low molecular 
weight aldehydes requires glutathione which implies that the substrate for ALDH-mediated oxidation may be 
the thiohemiacetal (Brabec, 1993).  
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Figure III.2 Metabolism of linear unsaturated carboxylic acid 
 
The resulting linear saturated/unsaturated carboxylic acids participate in normal fatty acid metabolism 
(Figure III.2). In this pathway, the carboxylic acid is condensed with coenzyme A (CoA) followed by 
catalytic dehydrogenation mediated by acyl CoA dehydrogenase (Voet and Voet, 1990). The resulting trans-
2,3-unsaturated ester (trans-delta2-enoyl CoA) is converted to the 3-ketothioester, which undergoes beta-
cleavage to yield an acetyl CoA fragment and a new thioester reduced by two carbons. 
Cleavage of acetyl CoA units will continue along the carbon chain until the position of unsaturation is 
reached. If the unsaturation begins at an odd-numbered carbon, acetyl CoA fragmentation will eventually 
yield a delta3-enoyl CoA, which cannot enter the fatty acid cycle until it is isomerised to the trans-delta2-
enoyl CoA by enoyl CoA isomerase. If unsaturation begins at an even-numbered carbon, acetyl CoA 
fragmentation yields a delta2-enoyl CoA product, which is a substrate for further fatty acid oxidation. If the 
stereochemistry of the double bond is cis, it is isomerised to the trans double bond by the action of 3-
hydroxyacyl CoA epimerase prior to entering the fatty acid oxidation pathway. Even-numbered carbon acids 
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continue to be cleaved to acetyl CoA while odd-numbered carbon acids yield acetyl CoA and propionyl 
CoA. Acetyl CoA enters the citric acid cycle directly while propionyl CoA is transformed into succinyl CoA 
that then enters the citric acid cycle. 
Alternate minor metabolic pathways have been characterised for linear long-chain fatty acids and short-chain 
carboxylic acids containing unsaturation. While linoleic and oleic acids participate in beta-oxidation and 
normal fatty acid metabolism in most tissues (Masoro, 1977), they may undergo omega-oxidation in the liver 
and alpha-oxidation in the brain (Wakil and Barnes, 1971; Gibson et al., 1982). 
Unsaturated short-chain carboxylic acids may be metabolised via saturation to yield a substrate that may 
participate in the fatty acid pathway. For example, the mechanism for oxidative metabolism of 4-pentenoic 
acid has been studied in rat heart mitochondria. In vitro 4-pentenoic acid is converted to the CoA thioester, 
which is dehydrogenated to yield the trans-2,4-pentadienoyl CoA (Figure III.3). Two enzyme-catalysed 
processes then compete for this conjugated thioester. In the first pathway, NADPH-dependent enzyme-
catalysed reduction of the delta4-alkene leads to trans-2-pentenoic acid. The second pathway involves beta-
oxidation to yield 3-keto-4-pentenoyl CoA. In vitro hydrogenation predominates to yield trans-2-pentenoic 
acid, which then participates in normal fatty acid oxidation (Schulz, 1983). 
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Figure III.3 Metabolism of 4-pentenoic acid 
III.3.3. Metabolism of Branched-chain Unsaturated Primary Alcohols, Aldehydes and Carboxylic Acids 
Generally, branched-chain aliphatic alcohols are oxidized to the corresponding aldehydes, which in turn are 
oxidized to the corresponding carboxylic acids (Bosron and Li, 1980; Levi and Hodgson, 1989). Branched-
chain aliphatic alcohols and aldehydes have been reported to be substrates for ADH (Hedlund and Kiessling, 
1969a; Albro, 1975) and ALDH (Hedlund and Kiessling, 1969a), respectively. As carbon chain length 
increases, the substrate-enzyme binding affinity with ADH (Pietruszko et al., 1973) and the rates of ALDH-
mediated oxidation also increase (Nakayasu et al., 1978). 
Similar to their saturated analogs, unsaturated branched-chain aliphatic alcohols and aldehydes are converted 
by the pathways cited above to the corresponding carboxylic acids, which participate in the normal fatty acid 
metabolism (Voet and Voet, 1990). 
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Alternatively, they may undergo a combination of omega, omega-1, and beta-oxidation to yield polar 
metabolites, which are excreted as such or as glucuronic acid conjugates in the urine (Diliberto et al., 1990). 
The principal metabolic pathways utilized for metabolisation of these branched-chain substances are 
determined primarily by four structural characteristics: carbon chain length, position of alkyl substituents, 
number of alkyl substituents and size of alkyl substituents. 
Short-chain (< C6) branched aliphatic carboxylic acids undergo beta-oxidation, preferentially in the longer 
chain. Beta-cleavage of the branched aliphatic carboxylic acids yields linear carboxylic acid fragments, 
which are sources of carbon in the fatty acid metabolism pathway or tricarboxylic acid cycle (Voet and Voet, 
1990). For example, a single oral dose of 4.5, 45 or 450 mg/kg [1-14C]-isobutyric acid given to male Charles 
River CD rats by gavage was rapidly eliminated in the breath as expired 14CO2. Within 24 hours of dosing, 
77, 78, or 83 % of the 4.5, 45 or 450 mg/kg dose, respectively, was eliminated as CO2 (DiVincenzo and 
Hamilton, 1979). 
Methyl methacrylate given to rats by gavage was also eliminated mainly as CO2 (Bratt and Hathway, 1977). 
The hydrolysis of one candidate substance hex-3-enyl-2-ethylburtyrate [FL-no: 09.884] generates 2-
ethylbutyric acid [FL-no: 08.045], which has some teratogenic potential (see Section 8.3). Although the 2-
ethyl-branched acid is resistant to beta-oxidation, it can be further conjugated with glucuronic acid or 
undergo omega-oxidation. However, the candidate substance [FL-no: 09.884] cannot be anticipated to be 
metabolised to an innocuous product. 
Terminal double bonds appear in eleven candidate substances [FL-no: 02.125, 02.138, 02.170, 02.175, 
02.176, 02.201, 05.143, 05.174, 09.612, 09.897 and 09.898]. Of these, six are unsaturated alcohols [FL-no: 
02.125, 02.138, 02.170, 02.175, 02.176 and 02.201] two are unsaturated aldehydes [FL-no: 05.143 and 
05.174], and three are esters [FL-no: 09.612, 09.897, and 09.898]. These double bonds may be oxidized to 
the corresponding epoxides. Epoxides are highly reactive molecules, due to the large strain associated with 
the three membered ring structure, and they react easily with nucleophilic sites of cellular macromolecules. 
For this reason, several aliphatic alkene-derived epoxides have been demonstrated to be carcinogenic (e.g. 
ethylene, isoprene, butadiene, glycidol) (Melnick, 2002). Alternatively, epoxides can be conjugated with 
glutathione (GSH) by glutathione S-tansferases (GSTs) or hydrolysed to diols by epoxide hydrolases (EHs). 
The latter two reactions can be considered to be detoxifications.  
It has been demonstrated that terminal double bonds may be oxidized at the double bond to give the 
corresponding epoxide or, alternatively, at the allylic carbon to give the allylic alcohol, as was demonstrated 
with 1-hexene with rat and human P450s (Chiappe et al., 1998). The ratio of epoxidation over allylic 
oxidation, as measured with different P450 isoforms (CYP) is ≥1, indicating that epoxide formation is 
generally favoured (Chiappe et al., 1998). Theoretically these pathways could occur with the candidate 
substances [FL-no: 02.125, 02.138, 02.175, 02.201, 05.143 and 05.174].  
In the same paper (Chiappe et al., 1998) it was demonstrated that the biotransformation of 2-methyl-1-
hexene proceeds exclusively via the epoxide, which was further hydrolysed by epoxide-hydrolase to the diol. 
This pathway might apply to the alcohols [FL-no: 02.170 and 02.176] and to the alcohol moiety of [FL-no: 
09.612, 09.897 and 09.898] 
However, the risk associated with the epoxidation of the terminal double bond of these candidate substances 
is expected to be low for several reasons:  
1) Epoxides can be metabolised by conjugation with glutathione or by epoxide-hydrolase mediated 
hydrolysis. 
2) The terminal double bonds are all present in molecules that have alcohol- or aldehyde functions 
at the end distal from the double bond, or that are alcohol moieties of esters. The alcohol- and 
aldehyde functions can be expected to be readily attacked by oxidation processes, ultimately 
yielding unsaturated carboxylic acids, and also hydrolysis of the esters would yield the 
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unsaturated alcohols, which will be oxidised to carboxylic acids. Biochemical attack of these 
carboxylic acids via e.g. beta-oxidation or conjugation with glucuronic acid is expected to be 
much more efficient and rapid than microsomal oxidation. 
Rats metabolised geraniol and citral (unsaturated branched-chain alcohol and aldehyde, respectively) largely 
via omega-oxidation to yield a mixture of diacids and hydroxy acids (Diliberto et al., 1990; Chadha and 
Madyastha, 1984). Geraniol related terpenoid alcohols (citronellol and nerol), and the aldehydes (geranial, 
citronellal and neral) exhibit similar pathways of metabolic metabolisation in animals (Figure III.4). 
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Figure III.4 Metabolism of Geraniol in rats 
 
Male rats were given repeated oral doses of 800 mg [1-3H]-geraniol/kg bw by gavage daily for 20 days. Five 
urinary metabolites were identified via two primary pathways. In one pathway, the alcohol is oxidized to 
yield geranic acid (3,7-dimethyl-2,6-octadieneoic acid), which is subsequently hydrated to yield 3,7-
dimethyl-3-hydroxy-6-octenoic acid. In a second pathway, the alcohol undergoes omega-oxidation mediated 
by liver cytochrome P-450 (Chadha and Madyastha, 1982) to yield 8-hydroxygeraniol. Selective oxidation at 
C-8 yields 8-carboxygeraniol, which undergoes further oxidation to the principal urinary metabolite 2,6-
dimethyl-2,6-octadienedioic acid (Chadha and Madyastha, 1984). 
Mono methyl substituted fatty acids are extensively metabolised to CO2 via beta-oxidative cleavage in the 
fatty acid pathway. If more than one methyl group is substituted in the lower as well as higher molecular 
weight acids or ethyl or propyl substituents are present, beta-oxidation is inhibited. In those cases 
metabolism involves direct conjugation of the acid with glucuronic acid, or omega-oxidation followed by 
conjugation (Williams, 1959a; Deuel, 1957). 
III.4. Summary and Conclusions 
In summary, it is anticipated that the esters in the group of candidate substances will undergo hydrolysis in 
the gastrointestinal tract, blood and liver to yield their corresponding aliphatic alcohols, aldehydes and 
carboxylic acids. Esters, aliphatic alcohols, aldehydes, and carboxylic acids are expected to be absorbed from 
the gastrointestinal tract. Alcohols would be oxidized to their corresponding aldehydes and carboxylic acids, 
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and aldehydes would be oxidized to their corresponding carboxylic acids. The resulting aliphatic carboxylic 
acids undergoes complete metabolism to CO2 in the tricarboxylic acid cyclic and fatty acid pathway. 
The following substances [FL-no: 02.170, 02.175, 02.176, 05.143, 09.341, 09.612, 09.643, 09.831, 09.871, 
09.872, 09.884, 09.897, 09.898 and 09.938] are not completely oxidised to CO2 due to substitution in the 
beta-position or steric hindrance. However, these substances are expected to undergo oxidation reactions and 
to be excreted as such or after conjugation with glucuronic acid. Hex-3-enyl-2-ethylburtyrate [FL-no: 
09.884], is hydrolysed to 2-ethylbutyric acid and hex-3-enol, which can be further conjugated with 
glucuronic acid or undergo omega-oxidation. However, the candidate substance [FL-no: 09.884] cannot be 
anticipated to be metabolised to an innocuous product. 
The risk associated with possible epoxidation of the candidate substances with terminal double bond is 
expected to be low for two reasons. Epoxides can be metabolised by conjugation with glutathione or by 
epoxide-hydrolase mediated hydrolysis. The terminal double bonds in this group of flavourings are all 
present in molecules that have alcohol- or aldehyde functions at the end distal from the double bond, and the 
alcohol and aldehyde functions are expected to be metabolised to carboxylic acids prior to epoxidation of the 
double bond. 
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ANNEX IV: TOXICITY 
Acute toxicity data are available for four candidate substances of the present flavouring group of 48 substances from chemical groups 1 and 4, and for 42 
supporting and structurally related substances evaluated by the JECFA at the 49th, 51st and 61st meetings (JECFA, 1998a; JECFA, 1999a; JECFA, 2004b). The 
supporting substances are listed in brackets. 
 
Table IV.1: ACUTE TOXICITY 
Chemical Name [FL-no] Species Sex Route LD50 (mg/kg bw) Reference Comments 
(4-Pentenoic acid [08.048]) Mouse NR Gavage 610 (Jenner et al., 1964)  
Rat M/F Gavage 470 (Jenner et al., 1964)  
Pent-4-enal [05.174] Rat F Gavage 620 (Smyth et al., 1962)  
(cis-3-Hexen-1-ol [02.056]) Mouse M Gavage 7000 (Gaunt et al., 1969)  
Mouse F Gavage 7200 (Gaunt et al., 1969)  
Rat M/F Oral 4700 (Moreno, 1973b)  
Rat M Gavage 10100 (Gaunt et al., 1969)  
Rat F Gavage 7300 (Gaunt et al., 1969)  
(cis-3-Hexenal [05.075]) Rat M/F Gavage 1560 (Palanker and Lewis, 1979)  
((Z,Z)-3,6-Nonadien-1-ol1 [02.189]) Rat M/F Oral 2000 (Koike, 1996)  
(cis-6-Nonenal [05.059]) Mouse NR Oral 5000 (Moreno, 1978b)  
(9-Decenal1 [05.139]) Mouse M/F Gavage 9500 (Johnson, 1980) LD50 > 5 ml/kg. 
(10-Undecenal [05.035]) Rat NR Oral 5000 (Hart and Wong, 1971)  
(10-Undecenoic acid [08.039]) Mouse NR Gavage  8150 (Newell et al., 1949)  
Mouse NR Oral 2300-6600 (Tislow et al., 1950)  
Rat NR Oral 2500 (Tislow et al., 1950)  
(Oleic acid [08.013]) Rat NR Oral 5000 (Moreno, 1977b)  
Rat NR Oral 19000 (Briggs et al., 1976) LD50 was > 21.5 ml for ocadecanoic 
acid (75 % oleic acid) and 
octadecadienoic acid (53 % linoleic 
acid, 23 % oleic acid). 
(cis-3-Hexenyl propionate1 [09.564]) Rat NR Oral 5000 (Moreno, 1976f)  
(cis-3-Hexenyl valerate1) Rat NR Oral 5000 (Moreno, 1978d) 1/10 rats died after a dose of 5000 
mg/kg. 
(Ethyl cis-4,7-octadienoate [09.290]) Rat M/F Gavage 10000 (Mondino, 1979)  
(Methyl 9-undecenoate [09.236]) Rat M Oral 3000 (Moreno, 1977b)  
(Ethyl 10-undecenoate [09.237]) Rat NR Oral 5000 (Moreno, 1977b)  
(Butyl 10-undecenoate [09.238]) Rat NR Oral 5000 (Moreno, 1977b)  
(Ethyl oleate [09.192]) Rat NR Oral 5000 (Bailey, 1976d) 1/10 rats died after a dose of 5000 
mg/kg. 
3-Methyl-but-3-en-1-ol [02.176] Rat NR Oral 5440 (BASF, 1968)  
(2,6-Dimethyl-5-heptenal [05.074]) Rat NR Oral 5000 (Levenstein, 1974b)  
Rat M/F Gavage 4550 (Mayyasi et al., 1981) LD50 > 5 ml/kg. 
Lavandulol [02.170] Mouse NR Oral 5000 (Moreno et al., 1982) 4/10 mice died after a dose of 5000 
mg/kg. 
(3-Hexenyl isobutyrate1 [09.563]) Rat  M/F Gavage 25000 (Moran et al., 1980)  
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Table IV.1: ACUTE TOXICITY 
Chemical Name [FL-no] Species Sex Route LD50 (mg/kg bw) Reference Comments 
Mouse M/F Gavage  25000 (Moran et al., 1980)  
(Hexyl 2-methyl-3&4-pentenoate [09.546]) Rat M/F Gavage 5000 (Elleman, 1979)  
(Ethyl 2-methyl-3,4-pentadienoate [09.540]) Mouse M Gavage 1316 (Babish, 1978c)  
Mouse F Gavage 892 (Babish, 1978c)  
Mouse M/F Gavage 770 (Moran et al., 1980)  
(Citronellyl formate [09.078]) Rat M/F Gavage 8400 (Calandra, 1971)  
(Geranyl formate [09.076]) Rat M/F Gavage 5460 (Weir and Wong, 1971a) LD50 > 6 ml/kg. 1/5 rats died after 6 
ml/kg. 
(Neryl formate [09.212]) Rat NR Oral  5000 (Moreno, 1975f)  
(Rhodinyl formate [09.079]) Rat NR Oral  5000 (Moreno, 1974a) 1/10 rats died after a dose of 5000 
mg/kg. 
(Citronellyl acetate [09.012]) Rat M/F Gavage 6800 (Calandra, 1971)  
(Geranyl acetate [09.011]) Rat M/F Gavage 6330 (Jenner et al., 1964)  
(Neryl acetate [09.213]) Rat M/F Gavage 4550 (Levenstein and Wolven, 1972a) LD50 > 5 ml/kg. 
(Rhodinyl acetate [09.033]) Rat M/F Gavage 5000 (Levenstein, 1973a) LD50 > 5 ml/kg. 
(Citronellyl propionate [09.129]) Rat NR Oral 5000 (Moreno, 1973a) 3/10 rats died after a dose of 5000 
mg/kg. 
(Geranyl propionate [09.128]) Rat NR Oral 5000 (Russell, 1973a)  
(Neryl propionate [09.169]) Rat NR Oral 5000 (Moreno, 1975f)  
(Rhodinyl propionate [09.141]) Rat NR Oral 5000 (Moreno, 1976h)  
(Citronellyl butyrate [09.049]) Rat NR Oral 5000 (Moreno, 1972a) 3/10 rats died after a dose of 5000 
mg/kg. 
(Geranyl butyrate [09.048]) Rat M/F Gavage 10660 (Jenner et al., 1964)  
(Rhodinyl butyrate) Rat NR Oral 5000 (Moreno, 1975f)  
(Geranyl hexanoate [09.067]) Rat NR Oral 5000 (Moreno, 1975f)  
(Citronellyl isobutyrate [09.421]) Rat NR Oral 5000 (Denine and Palanker, 1973a)  
(Geranyl isobutyrate [09.431]) Rat NR Oral 5000 (Shelanski and Moldovan, 1973a)  
(Neryl isobutyrate [09.424]) Rat M Oral 5000 (Moreno, 1980d)  
(Rhodinyl isobutyrate)  Rat NR Oral 5000 (Moreno, 1975f)  
(Geranyl isovalerate [09.453]) Rat NR Oral 5000 (Levenstein, 1975a)  
(Geranyl 2-ethylbutanoate [09.515]) Mouse NR Oral 8000 (Pellmont et al., 1968)  
Undec-10-en-1-ol [02.125] Rat M/F Oral 5000 (Levenstein and Wolven, 1972c) LD50 > 5 ml/kg. 
NR: Not Reported 
1 A substance evaluated at the 61st JECFA meeting structurally related to candidate substances in FGE.06.
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Subacute / subchronic / chronic /carcinogenicity toxicity data are available for 12 supporting substances of the present flavouring group. They were evaluated at 
the 49th and 51st JECFA meetings (JECFA, 1998a; JECFA, 1999a). No repeated dose studies are available on the candidate substances. The supporting 
substances are listed in brackets. 
Table IV.2: Subacute / Subchronic / Chronic / Carcinogenicity Studies 
Chemical Name [FL-no] Species; Sex 
No./Group 
Route Dose levels Duration NOAEL  
(mg/kg 
bw/day) 
Reference Comments 
(cis-3-Hexen-1-ol [02.056]) Rat; M, F 
30 
Drinking water 0, 310, 1250, 5000 
ppm equal to M: 0, 
30, 127, 410 mg/kg 
bw/day, F: 0, 42, 
168, 721 mg/kg 
bw/day 
98 days 127-168 (Gaunt et al., 1969) NOAEL corresponds to 1250 mg/kg feed. 
(10-Undecenoic acid [08.039]) Rat; M, F 
NR 
Gavage 0, 100, 200, and 400 
mg/kg bw/day 
6 months 400 (Tislow et al., 1950) Total number of animals studied was 152. 
Endpoints included body weight and changes in 
autopsy (only poorly reported abstract available). 
Rat; M 
7 
Diet 0, 5000, 10000 and 
25000 mg/kg feed 
equivalent to 0, 500, 
1000 and 2500 mg/kg 
bw/day 
8 weeks 25003  (Newell et al., 1949) Reported only data on body weight. Study ongoing 
at the reporting time. There was a reduction in 
body weight gain at both concentration. Doses are 
considered very high. 
(Oleic acid [08.013]) Rabbit; M, F 
20 
Diet 0, 150000 mg/kg 
feed equivalent to 
4500 mg/kg bw/day 
36 weeks 45003 (Borgman and Wardlaw, 
1975) 
Groups: (1) olive oil and (2) semipurified oleic 
acid. Treatment included periods with diet 
supplemented with cholesterol. Serum cholesterol 
was the main endpoint. Rabbits fed oleic acid 
began to deteriorate by week 17th. Animals showed 
severe to slight hepatic fatty acid degeneration. 
Mouse; NR 
36 and 55 
Diet 0, 1500 mg/kg feed 
equivalent to 0, 225 
mg/kg bw/day 
24 months 2253 (El-Khatib and Cora, 1981) Groups were given (1) normal diet, or (2) normal 
diet + corn oil (10 %) + oleic acid (0.15 %). Main 
endpoint was lipid content in the liver and pituitary 
gland. There was an increase. In 3 of 36 surviving 
mice given diet with corn oil + oleic acid 
adenocarcinoma of the colon was reported. 
Rabbit; M, F 
38-42 
Diet 0, 150000 mg/kg 
feed equivalent to 0, 
4500 mg/kg bw/day 
16 weeks 45003 (Lee et al., 1986) Treated animals were given a diet with 40 % casein 
and 15 % oleic acid. Examined for gallbladder 
content. The treated animals showed gallstones. 
(Oleic acid/linoleic acid mixture 
[08.013] / [08.041]) 
 
Mouse; M, F 
329-623 
Oral (given on 
a separate dish) 
0, 0 and ~ 64-100 
mg/kg bw/day 
≈ 24 months 
(long term, 
exact duration 
not reported) 
64-100 (Szepsenwol and Boschetti, 
1975) 
A NOAEL was not determined. Groups: (1) 
untreated (2) refined corn oil, (3) refined corn oil 
with 15 mg/g oleic acid/linoleic acid mixture. Mice 
given treatment (3) had a higher incidence of 
stomach tumours as compared to the other two 
groups. 
Mouse; NR 
195-328 
Oral (given on 
a separate dish) 
0, 0, 0, and ~ 85-100 
mg/kg bw/day 
≈ 24 months 
(long term, 
exact duration 
not reported) 
85-100 (Szepsenwol, 1978) A NOAEL was not determined. Groups: (1) 
untreated, (2) refined corn oil, (3) crude corn oil, 
and (4) refined corn oil + oleic acid/linoleic acid 
mixture. The mixture oleic acid/linoleic acid was 
carcinogenic, with an increased incidence of 
forestomach papilloma, squamous cell carcinoma 
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Table IV.2: Subacute / Subchronic / Chronic / Carcinogenicity Studies 
Chemical Name [FL-no] Species; Sex 
No./Group 
Route Dose levels Duration NOAEL  
(mg/kg 
bw/day) 
Reference Comments 
and pyloric tumours. 
(Hexanoic acid1 [08.009]) Rat; M, F 
10 
Diet 100000 mg/kg feed 
equivalent to 5000 
mg/kg bw/day 
5 months 50003 (Mori, 1953) Endpoint was gastric lesions. No attempt was made 
to estimate the amount ingested by rats due to the 
volatility of fatty acid, which raises concerns on 
the validity of the results. 
(2,6-Dimethyl-5-heptenal [05.074]) Rat; M, F 
30 
Diet 0, 9, 37, and 150 
mg/kg bw/day 
3 months 37 (Gaunt et al., 1983)  
(2-Ethylbutyric acid1 [08.045]) Rat; M, F 
6 
Diet 6000 mg/kg feed 
equivalent to 300 
mg/kg bw/day 
3 months 3003 (Amoore et al., 1978)  
(Citronellyl acetate and geranyl acetate 
[09.012] and [09.011]) 
Mouse; M, F 
20 
Gavage 0, 125, 500, 1000, 
and 2000 mg/kg 
bw/day 
13 weeks 1000 (NTP, 1987a) The test material was composed of 71 % geranyl 
acetate and 29 % citronellyl acetate.  
Rat; M, F 
20 
Gavage 0, 250, 500, 1000, 
2000, and 4000 
mg/kg bw/day 
13 weeks 2000 (NTP, 1987a) The test material was composed of 71 % geranyl 
acetate and 29 % citronellyl acetate. 
Mouse; M, F 
100 
Gavage 0, 500, and 1000 
mg/kg bw/day 
2 years 500 (NTP, 1987a) The test material was composed of 71 % geranyl 
acetate and 29 % citronellyl acetate. Survival 
among males was 62, 64 and 0 %, respectively. 
Survival among females was 50, 30, and 0 %, 
respectively. The mixture was not considered to be 
carcinogenic. 
 Rat; M, F 
100 
Gavage 0, 1000, and 2000 
mg/kg bw/day 
2 years 1000 (NTP, 1987a) The test material was composed of 71 % geranyl 
acetate and 29 % citronellyl acetate. Survival 
among males was 68, 58 and 36 %. Survival 
among females was 70, 56 and 66 %, respectively. 
The mixture was not considered carcinogenic. 
(Geranyl acetate [09.011]) Rat; M, F 
20 
Diet 0, 1000, 2500, and 
10000 mg/kg feed 
equivalent to 0, 50, 
125, 500 mg/kg 
bw/day 
17 weeks 5003 (Hagan et al., 1967)  
(Geraniol2 [02.012]) Rat; M, F 
10 
Diet 0, 10000 mg/kg feed 
equivalent to 500 
mg/kg bw/day 
16 weeks 5003 (Hagan et al., 1967)  
Rat; M, F 
10 
Diet 0, 1000 mg/kg feed 
equivalent to 50 
mg/kg bw/day 
27 – 28 weeks 503 (Hagan et al., 1967)  
(Citronellol2 [02.011]) Rat; M, F 
30 
Diet Incompletely 
reported 
12 weeks 50 (Oser, 1967) The test material was a mixture consisting of equal 
amounts of citronellol and linalool. The 
publication was not provided, only a FAO report 
referring to it. There was a slightly retarded growth 
of males, without effect on food utilization. No 
other endpoints are mentioned. 
(Citronellyl isobutyrate [09.421]) Rat; M, F 
28 
Diet 0, 14.7 mg/kg 
bw/day 
3 months 14.7 (Damske et al., 1980d)  
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NR = Not Reported. 
NA = Not Applicable.  
1A substance evaluated at the 49th JECFA meeting and structurally related to candidate substances in FGE.06. 
2 A substance evaluated at the 61st JECFA meeting structurally related to candidate substances in FGE.06. 
3 Conversion table for test chemical treatment dosed used in PAFA (FDA, 1993). 
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No developmental and reproductive toxicity studies are available for any candidate substance in the present flavouring group. One study was available for one 
supporting substance and for one hydrolysis product.  
TABLE IV.3: DEVELOPMENTAL / REPRODUCTIVE TOXICITY STUDIES 
Table IV.3: Developmental / Reproductive Toxicity Studies 
Chemical name Study type 
Duration 
Species/sex  
No/group 
Route Dose levels NOAEL 
mg/kg/day 
Including information on 
possible maternal toxicity 
Reference Comments 
(10-Undecenoic acid [08.039]) One generation study 
9 months  
Rat; M, F 
NR 
Gavage  
 
NR NR (Tislow et al., 1950) Only poorly reported 
abstract available. 
(2-Ethylbutyric acid [08.045]) Developmental toxicity; dose 
administered gestation days 6-15 
Rat; F 
9-18 
gavage 0, 150, 200 mg/kg bw 200 (Narotsky et al., 1994)  
Developmental toxicity; dose 
administered gestation day 8 
Mouse; F 
15/group 
Subcutaneo
us injection 
0, 600 mg/kg bw < 600 (Nau and Löscher, 1986) 1 
NR = Not Reported. 
1) In the present study valproic acid as well as a number of related substances was examined with respect to their teratogenic potential. Valproic acid was highly teratogenic at 600 mg/kg/day. The study showed that the teratogenic potential increased 
with the number of carbon-atoms in the 2-position. 
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In vitro mutagenicity/genotoxicity data are available for one candidate substances of the present flavouring group evaluation from chemical group 4 and for six 
supporting substances evaluated at the 49th and 51st JECFA meetings (JECFA, 1998a; JECFA, 1999a). Supporting substances are listed in brackets. 
Table IV.4: GENOTOXICITY (in vitro) 
Chemical Name [FL-no] Test system Test Object Concentration Result Reference Comments 
 
(9-Decenal1 [05.139]) Ames assay S. typh. TA98, TA100, 
TA1535, TA1537, 
TA1538 
0.001-1 nl/plate (0.001-1 
μg/plate)  
Negative2 (Richold and Jones, 1980) In the absence of metabolic activation, the 
highest concentrations were cytotoxic. The study 
is considered valid. 
(Oleic acid [08.013]) Ames assay S. typh. TA98, TA100, 
TA1535, TA1537, 
TA1538, E. coli 
WP2uvrA 
1 - 5000 μg/plate Negative2 (Shimizu et al., 1985) Modified Ames, preincubation assay. The study 
is considered valid. 
Ames assay S. typh. TA98, TA100, 
TA1535, TA1537 
1 - 333 μg/plate Negative2 (Mortelmans et al., 1986) Modified Ames, preincubation assay. 
Concentrations were selected based on a 
preliminary experiment. The study is considered 
valid. 
Rec assay B. subtilis 100 - 1000 μg/plate Negative2 (Osawa and Namiki, 1982) The validity of this study is unclear. 
SCE test CH V79 2.5 - 10 μg/ml  Negative  (Kinsella, 1982) Not cytotoxic. The assay was only performed 
without metabolic activation. Doses were 
selected based on a preliminary assay. The study 
is considered valid. 
Chrom. abs. CH V79 2.5 - 10 μg/ml  Positive (Kinsella, 1982) There was an increase in numerical 
abnormalities, but not in breaks, not 
concentration dependent. No cytotoxicity was 
observed. The assay was only performed without 
metabolic activation. Doses were selected based 
on preliminary assay. The study is considered 
valid. 
6-TG resistance CH V79 1.0 μg/ml  Negative  (Kinsella, 1982) Not cytotoxic. Only one concentration level. The 
assay was only performed without metabolic 
activation. The validity of the study cannot be 
evaluated. 
(Methyl linoleate & Methyl linolenate (mixture) 
[09.646]) 
Ames (His+ reversion) 
assay 
S. typh. TA100, TA98, 
TA102, TA97, TA1537 
125 - 1000 μg/plate Negative2 (MacGregor et al., 1985) Tests were conducted with methyl linoleate and 
methyl linolenate separately. Both were 
negative. Doses were selected based on 
prelimary assay. The study is considered valid. 
3-Methyl-but-3-en-1-ol [02.176] Ames assay S. typh. TA98, TA100, 
TA1535, TA1537 
20 - 5000 μg/plate Negative2, 5  (BASF, 1989c) The complete report for this study was not 
provided. The validity of this study cannot be 
evaluated. 
(2,6-Dimethyl-5-heptenal [05.074]) Ames assay S. typh. TA98, TA100, 
TA1535, TA1537, 
TA1538 
Up to 3600 μg/plate Negative2 (Wild et al., 1983) Five concentrations tested. The study is 
considered valid. 
Ames assay S. typh. TA98, TA100, 
TA1535, TA1537, 
TA1538 
Up to 50000 μg/plate Negative2 (Heck et al., 1989) No information concerning a possible cytotoxic 
effect nor on the number of concentrations 
tested. The test guidelines do not require more 
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Table IV.4: GENOTOXICITY (in vitro) 
Chemical Name [FL-no] Test system Test Object Concentration Result Reference Comments 
 
than 5 mg/plate. The validity of this poorly 
reported study cannot be evaluated. 
UDS test Rat hepatocytes Up to 1000 μg/ml Negative2 (Heck et al., 1989) No information concerning the number of 
concentrations tested. The validity of this poorly 
reported study cannot be evaluated. 
(Geranyl formate [09.076]) Rec assay B. subtilis 18 μg/disk  Negative (Oda et al., 1979) From english abstract. Only one dose level is 
mentioned in a table. The validity of the study is 
unclear. 
(Geranyl acetate [09.011]) Ames assay S. typh., TA98, TA100, 
TA1535  
Up to 2000 μg/plate  Negative (Heck et al., 1989) No information concerning a possible cytotoxic 
effect nor on the number of concentrations 
tested. The validity of this poorly reported study 
cannot be evaluated.  
Ames assay S. typh., TA98, TA100, 
TA1535, TA1537 
1 - 3333 μg/plate  Negative (Mortelmans et al., 1986) Modified Ames, preincubation assay. Doses 
were selected based on preliminary assay. The 
study is considered valid. 
Rec assay B. subtilis 17 μg/disk  Negative  (Oda et al., 1979) From english abstract. Only one dose level is 
mentioned in a table. The validity of this study is 
unclear. 
Rec assay B. subtilis Up to 20 μl/disk  Negative  (Yoo, 1986) From english abstract. No information 
concerning the number of doses tested. The 
validity of this study cannot be evaluated. 
Gene mutation Mouse; L5178Y TK+/-  Up to 100 μg/ml 
Up to 78 μg/ml 
Negative3;  
Positive4 (weak) 
(Heck et al., 1989) The validity of this poorly reported study cannot 
be evaluated. 
Gene mutation Mouse; L5178Y TK+/-  18.3 μg/ml Negative3;  
Positive4 
(Tennant et al., 1987) Detailed information on this study was not 
provided. The article includes a table presenting 
the results of different genotoxicity and 
carcinogenicity tests performed with several 
compounds.  
SCE test CHO cells 45 - 80 μg/ml;  
50 - 299 μg/ml 
Positive (weak)3;  
Positive (weak) or 
negative 4  
(Galloway et al., 1987a) Positive results, without metabolic activation, 
were observed at cytotoxic concentrations. 
Doses were selected based on preliminary assay. 
The study is considered valid. 
Chromosomal 
aberrations 
CHO cells 60 - 100 μg/ml;  
50 - 150 μg/ml 
Negative3;  
Negative4 
(Galloway et al., 1987a) Doses were selected based on preliminary assay. 
The study is considered valid. 
UDS test Hepatocytes of F344 
male rats 
NR Negative (Mirsalis et al., 1983) Only an abstract is available. The validity of this 
study cannot be evaluated. 
Inhibition of DNA 
synthesis 
CHO cells 113 μmole Negative (Meigs et al., 1995) Only one concentration level is mentioned. The 
validity of this study is unclear. 
UDS test Hepatocytes of F344 
male rats 
Up to 100 nl/ml Negative (Heck et al., 1989) No information concerning the number of 
concentrations tested. The validity of this poorly 
reported study cannot be evaluated. 
Gene mutation Human lymphoblast 
TK6  
Up to 320 μg/ml;  
Up to 500 μg/ml 
Negative3;  
Negative4 
 
(Caspary et al., 1988) Compound precipitation was the limiting factor 
for the maximum concentration. The study is 
considered valid. 
NR = Not Reported. 
1 A substance evaluated at the 61st JECFA meeting structurally related to candidate substances in FGE.06.  
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2With and without metabolic activation.  
3Without rat liver S-9 activation.  
4With rat liver S-9 activation. 
5 3-Methyl-but-3-en-1-ol [FL-no: 02.176] (purity not reported) was tested in a bacterial reversion assay (Ames test) with Salmonella typhimurium strain TA1535, TA100, TA1537 and TA98 with and without exogenous metabolic activation (origin not 
reported), following the standard plate test and pre-incubation test. It is not reported whether a dose range-finding experiment was performed. The main experiments were conducted at a not reported number of doses from 20 to 5000 microgram/plate. 
It is not reported whether the doses were tested in duplicate or triplicate. It is not reported the identity of the solvent. 
Result: negative. Eventual bacteriotoxicity or precipitation is not reported.  
Remarks: the available report mentions that the study was performed in accordance with the OECD Guideline 471 “Genetic Toxicology: Salmonella thyphimurium Reverse Mutation Assay”. The available report does not contain sufficient details nor 
is it published in a peer-reviewed journal. The validity of this study cannot be evaluated. 
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In vivo mutagenicity/genotoxicity data are available for two supporting substances of the present flavouring group. They were evaluated at the 49th and 51st 
JECFA meetings (JECFA, 1998a; JECFA, 1999a). The supporting substances are listed in brackets.  
Table IV.5: GENOTOXICITY (in vivo) 
Chemical Name [FL-no] Test system Test Object Route Dose Result Reference Comments 
(2,6-Dimethyl-5-heptenal [05.074]) Mouse micronucleus assay NMRI male and female 
mouse bone marrow  
NR 420 - 1540 
mg/kg 
Negative (Wild et al., 1983) Mice received a single dose. Dose levels were 
not justified. The validity of this study cannot be 
evaluated. 
Basc test D. melanogaster NR 25 mM Negative (Wild et al., 1983) Only one dose is mentioned. The validity of this 
study is unclear. 
(Geranyl acetate [09.011]) Mouse micronucleus assay B6C3F1 mouse bone 
marrow cells 
i.p. 450 - 1800 
mg/kg 
bw/day 
Negative (Shelby et al., 1993) Selection of maximum dose was justified. The 
study is considered valid. 
Unscheduled DNA synthesis F344 male rats hepatocytes Gavage NR Negative (Mirsalis et al., 1983) Only an abstract is available. The validity of this 
study cannot be evaluated. 
NR = Not Reported.  
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ABBREVIATIONS 
ADI  Acceptable Daily Intake 
ADH  Alcohol dehydrogenase 
ALDH  Aldehyde dehydrogenase 
BW  Body weight 
CAS  Chemical Abstract Service 
CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
Chemical Abstract Service 
CHO  Chinese hamster ovary (cells) 
CoA  Coenzyme A 
CoE  Council of Europe 
DNA  Deoxyribonucleic acid 
EC European Commission 
EFSA  The European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GSH  Glutathione 
GST  Glutathione S-transferase 
ID   Identity 
IOFI  International Organization of the Flavour Industry 
IR   Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
LD50  Lethal Dose, 50%; Median lethal dose 
MS  Mass spectrometry 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NAD  Nicotinamide Adenine Dinucleotide  
NADH  Nicotinamide Adenine Dinucleotide, reduced form 
NADP  Nicotinamide Adenine Dinucleotide Phosphate 
NADPH Nicotinamide Adenine Dinucleotide Phosphate, reduced form 
No  Number 
NOAEL No Observed Adverse Effect Level 
NOEL  No Observed Effect Level 
NTP  National Toxicology Program 
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SCE  Sister Chromatid Exchange 
SCF  Scientific Committee on Food 
SMART  Somatic Mutation and Recombination Test  
TAMDI Theoretical Added Maximum Daily Intake 
UDS  Unscheduled DNA Synthesis  
WHO  World Health Organisation 
